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SUMMARY
Defibrillation is termination of arrhythmias by altering the transmembrane voltage through
the delivery of electric shocks. It has been known for over 100 years that electrical shocks
can both initiate and terminate fibrillations. Debates on the mechanisms behind defib-
rillations, however, have never ceased. More recent studies affirmed the contribution of
inhomogeneities to depolarization in tissues during a defibrillation shock, stating the het-
erogeneities, such as vessels and bundles, which have different electrical conductivities
than cardiac tissue, serve as virtual electrodes during an electric shock, creating excitations
in tissues far away from the anode and cathode [1].
Low energy anti-fibrillation pacing (LEAP) has been suggested as an alternative method
to traditional defibrillation method, which applies a strong electric pulse to terminate the
arrhythmia. LEAP delivers multiple low amplitude electric shocks through field electrodes
close to, or inside the tissue [2, 3]. The main goal of this thesis is to investigate the mecha-
nism of LEAP and to suggest ways to improve it.
The main finding is that LEAP works by gradually synchronizing the electric activity
to the same frequency through each additional shock. Because the tissue is synchronized
to the same frequency, both depolarization and repolarization are synchronized and ad-
ditional shocks will not restart arrhythmia. Modified Kuramoto phase diagrams showed
that, during arrhythmias, phase is relatively evenly distributed, and once LEAP is applied,
the phase over the domain is increasingly focused with each shock. To further quantify
this synchronicity, we calculated the fraction of tissue excited (FTE) as a function of time.
The FTE peak progressively increases to one with each pulse for successful LEAP and its
derivative indicates how fast the tissue synchronizes. In contrast, during one-shock defib-
rillation, the FTE upstroke is much slower compared to LEAP, indicating that all cells are
eventually excited but not at the same time. Therefore, the mechanism of one-shock defib-
rillation is not through synchronization but rather by resetting all cells to an excited state,
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which requires the use of stronger electrical shocks, as some cells are less excitable than
the others due to the repolarization gradients during fibrillation.
Numerical simulations in this study suggested some ways to improve LEAP by adjust-
ing the pacing period as well as the shock timings. The success rate is higher when the
pacing cycle length is close to the dominant period of the arrhythmia and when the first





Cardiovascular disease is the leading cause of death in the United States, accounting for
over 800,000 deaths in 2014 [4]. Atrial fibrillation (AF) is the most common sustained car-
diac arrhythmia affecting between 2.7 to 6.1 million Americans with a projected increase to
approximately 12.1 million by 2030 [4]. Complications associated with chronic AF include
an increased risk for both thromboembolism and stroke due to clot formation [5] and was
the underlying cause of death for 21,713 Americans in 2014 [4]. Ventricular fibrillation
(VF) is the most commonly identified arrhythmia in cardiac arrest patients, mentioned on
353,427 death certificates in the US in 2014 [4]. It is crucial to identify the mechanisms of
AF and VF and find more effective treatments.
Using computational simulations we can reduce the number of animal experiments,
easily adjust parameters and shed light on problems that are difficult to experiment. Since
in simulations it is much easier to control the environment to allow varying only a few
important factors, they are particularly useful in offering insights into the mechanism of
fibrillation and optimizing parameters for defibrillation.
1.2 Problem description
Standard defibrillation, which resets the heart with one strong shock, remains the mainstay
treatment for symptomatic patients [6, 7]. However, acute electrical shocks are associated
with severe side effects including electroporation, tissue damage, conduction disturbance,
and pain in patients [8, 9, 10].
Recently, low energy anti-fibrillation pacing (LEAP) has been suggested as an alterna-
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tive method. LEAP delivers multiple low amplitude electric shocks through field electrodes
close to, or inside the tissue [2, 3]. The central mechanism behind defibrillation lays on the
generations of virtual electrodes [11, 12, 13] or secondary excitation sources originating
at heterogeneities in tissue such as trabecula, vessels, bundles, and abrupt changes in fiber
direction. Excitations from virtual electrodes act as a multitude of intramural implanted
defibrillation electrodes that allow to terminate arrhythmias inside the tissue. An otherwise
entirely homogeneous heart will only be activated at boundaries by electric field and de-
fibrillation would never be possible. For single defibrillation shocks to work, they have
to provide enough energy to synchronize the whole domain in one single shock while for
multiple shocks as in LEAP, we hypothesize that each low energy pulse gradually recruits
more tissue to a given frequency until all tissue has been synchronized [2, 3].
To acquire trustworthy results from simulations for defibrillation studies, it requires
using realistic cardiac models in both physiology and geometry.
At present, there are close to a hundred mathematical models describing the electro-
physiology and dynamics of single cardiomyocyte. However, most of them focus only on
ion channels and sarcoplasmic reticulum (SR) dynamics without including the equations
to simulate the contraction. This is a considerable drawback since electrical activities and
mechanics are closely related.
In addition, there exists a large discrepancy in the results between single cell and tissue
simulations for recently developed and widely used models[14]. It is necessary to compare
them with experiments and validate them.
1.3 Outline
In this thesis, I first give an introduction to normal and abnormal heart rhythm and review
the theories of one major abnormal function: fibrillation (Chapter 2). Then I review equa-
tions and numerical schemes used in cardiac modeling for this thesis (Chapter 3). Next, in
Chapter 4, we developed a systematic methodology to implement contraction into electro-
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physiology models and validate their calcium and contraction behaviors comparing them
with experiments. In Chapter 5, we compared the voltage and calcium alternans dynamics
from a widely used calcium model with dual voltage-calcium optical mapping experiments.
In Chapter 6, we combined experiments with simulations to discover the mechanism of
low-energy anti-fibrillation. In Chapter 7, we used the WebGL-accelerated simulations to
explore the influence of multiple factors on the defibrillation results. And we draw conclu-




In this Chapter, I first give a brief description of normal and abnormal heart functions. Then
I discuss the induction of alternans, and its relation to the calcium signaling in the heart.
Then we review the current major theories on fibrillation and defibrillation.
2.1 Normal heart function
The human heart is composed of four chambers: the right/left atria (RA/LA), which collect
deoxygenated/oxygenated blood from the body/lungs, and the right/left ventricle (RV/LV),
which pump the blood to the lungs/body. Contraction of the heart is the driving force for
the circulation system.
The contraction of the heart is coordinated by electric signals, represented by the trans-
membrane voltage, a voltage difference between the intracellular and extracellular space.
The elevated transmembrane voltage is called an action potential (AP). In a single cell, the
AP is created by ions entering and exiting the membrane and this process can be divided
into five phases. Phase 4 is when AP is at its resting value (about −84mV ). With some
perturbations, the AP rises above the excitation threshold (about −65mV ) which activates
the Na+ channel. Large amount of Na+ ions flowing into the cell causes the AP to rise
rapidly. This is the depolarization (upstroke), phase 0, of an AP. Then Na+ channels close
and K+ channels open. K+ ions flow out of the cell, causing the AP to drop. This is the
peak, phase 1, of an AP. While K+ ions keep flowing out, Ca2+ enters the cytoplasmic
space, balancing K+, causing a flat plateau of AP; this is phase 2. Then phase 3 starts
when both Ca2+ and K+ are exiting the intracellular space, causing AP to drop; this is the
repolarization of AP. After that, AP drops back to resting state and the process goes back
to phase 4 again (Fig. 2.1).
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Figure 2.1: Action potential, action potential duration and diastolic interval
The duration of the action potential above a chosen threshold is called an action poten-
tial duration (APD), during which the ventricles are contracting, ejecting blood out of the
heart. The interval between two adjacent APs (phase 4) is called a diastolic interval (DI),
during which the ventricles are relaxed and blood refill the heart. The duration of a whole
cycle is called a cycle length (CL=APD+DI, see Fig. 2.1). If APD is not adjusted at a faster
heart rate, DI will be reduced, leading to insufficient refill of the blood. In reality, when
the heart beats at a higher frequency, the ionic gates are not fully recovered, resulting in
a reduced ionic current, and thus shortened both APD and DI, therefore adequate time is
distributed between systoles and diastoles.
In normal hearts, action potentials are generated in a regular rhythm from only the
sinoatrial (SA) node (a patch of natural pacemaker cells located on the upper part of the
RA), meaning APD, DI and CL are kept relatively constant, and APs only propagate from
the base (top) to the apex (bottom) of the heart through the atrioventricular (AV) node
located at the bottom part of the RA.
Intracellular calcium handling plays an essential role in cardiac cell dynamics, includ-
5
ing ion homeostasis, intracellular signaling, and contraction.
Figure 2.2 shows the different compartments and ion channels in a cell involved in the
intracellular calcium cycling during an action potential [15]. During the depolarization,
L-type calcium channels are activated and the influx of calcium current into the narrow
dyadic space induces a large calcium release from the Junctional Sarcoplasmic Reticulum
(JSR) through clusters of Ryanodine Receptors (RyRs). Intracellular calcium concentration
is thus greatly increased immediately following the depolarization of the transmembrane
action potential. Some of these calcium ions bind to affinity sites on myofilament protein
Troponin C therefore enable myosin heads, which contain cross-bridges, to attach to actin.
Myosin heads walk on actin generating force, transforming chemical energy to mechanical
energy resulting in cell contraction. Then during the repolarization of the action poten-
tial, calcium leaves the cytoplasmic compartment into either the Network Sarcoplasmic
Reticulum (NSR) through the Ca-ATPase pump or out of the cell membrane though Na-Ca
exchangers. The decreased intracellular calcium concentration causes calcium to detach
from troponin C, inducing uncoupling of Myosin heads and actin, which ends the contrac-
tion process. Calcium is deeply involved in both the electrical activation and the tension
generation.
2.2 Abnormal heart function
Abnormalities in the initiation or propagation of APs can cause pathologic heart rhythms,
called cardiac arrhythmias. For example, action potentials can be fired from pulmonary
veins other than the SA node [16]; and they can be propagated to ventricles through acces-
sory pathways by the bundle of Kent rather than the AV node (the Wolff-Parkinson-White
syndrome [17]).
Arrhythmias can be classified in different ways. One way is based on the heart rate.
Bradycardias refer to heart rates slower than normal (below 60 beats per minute). It is
usually caused by abnormally slow sinus rhythm, secondary slower pacemaker (such as the
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Figure 2.2: Intracellular calcium signaling. Figure from [15]
AV node) taking over or normal sinus rhythm being blocked. Patients with bradycardias
are usually treated with drugs that can increase the heart rate or implanted pacemakers that
can take over the heart to maintain a normal heart rate [18].
Tachycardias refer to the heart rates faster than normal (above 100 beats per minute).
During ventricular tachycardia (VT), blood is not pumped efficiently by the heart, which
will cause less oxygenated blood delivered to the body therefore patients will feel weak-
ness and dizziness. Tachycardias can degenerated into fibrillations during which patients
have completely disorganized rhythms and ventricular fibrillations (VF) can lead to sudden
cardiac arrests when no blood is pumped [18].
Tachycardia and fibrillation can be induced in many ways. One way is through reen-
try. In a normal heart, action potentials propagate as an almost simultaneous wave. Un-
der pathological conditions, however, an action potential might not complete its normal
pathway but rather circles back upon itself, forming long-lasting self-sustained excitations,
taking the form of a spiral wave (2D) or a scroll wave (3D). It has been shown that spiral
waves in the heart could be responsible for deadly arrhythmias such as tachycardias and
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fibrillations [19].
Alternans happens when the action potential duration varies from one beat to the next.
This long-short alternation in duration and in some cases amplitude has been shown to
arise from a period-doubling bifurcation [20, 21], originating at the cellular level [22].
In space, alternans can lead to complex spatiotemporal patterns along the epicardium and
endocardium [23] and eventually to conduction block and fibrillation [24, 25].
2.3 Mechanism of alternans and reentry
During fast pacing, alternate patterns of APD in space can be classified as concordant
alternans (CA), in which all the tissue responds with a long APD on one beat and with a
short APD on the following beat with the sequence repeating, or discordant alternans (DA),
in which one section of tissue responds with a long APD and another with a short APD on
the same beat followed by the reverse on the next beat. Figure 2.3 shows an example of
concordant and discordant alternans from a simulation. A 3cm long 1D cable is paced from
the left end. The left panels show the APD over the cable for two consecutive beats and
the right panel shows the action potential time sequence in two cells located at the left and
right end of the cable. In Fig. 2.3a, the pacing cycle length is 300ms. The APD alternates
between long and short for two consecutive beats and the whole cable follows the same
pattern thus it is in concordant alternans. In Fig. 2.3b the pacing cycle length is 260ms.
The APD profile along the cable for two consecutive even and odd beats intersect at a
nodal point, indicating when part of the cable undergoes a long, the other part undergoes a
short APD, which means the cable is in discordant alternans.
To date, two main mechanisms for the development of discordant alternans have been
proposed, one driven by voltage and another by calcium [26, 27]. The first mechanism
identified [21] was purely voltage-driven [20]; in space it is coupled through the dynamical
interaction between the APD restitution curve and the conduction velocity (CV) restitution
curve.
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(a) Concordant alternans, T = 300ms
(b) Discordant alternans, T = 260ms
Figure 2.3: Demonstration of concordant and discordant alternans. Left panel: APD over a
3cm 1D cable. Right panel: action potential of two cells, one at the left side and one at the
right side of the cable.
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The APD-DI restitution curve is the relation between APD and its preceding DI. It
shows APDn as a function of DIn−1 (Fig. 2.1). The preceding DI will not only affect
APD, but will also influence the propagating speed. The conduction velocity restitution
curve shows the wave front conduction velocity (CV) at a given site as a function of the
proceeding DI at that site.
When tissue is paced rapidly, diastolic intervals are shorter, causing slower CV near the
stimulating site while CV increases downstream along wavefront propagation, causing a
large spatial dispersion in the APD that can lead to DA [28, 29].
The other mechanism, calcium-driven, is considered more complex, with DA caused by
instabilities in calcium cycling that in turn impacts APD through Ca - Vm coupling [30].
Ca - Vm coupling depends on a dynamical balance between the influx through the L-type
calcium current (ICaL) and the outflux through the Na-Ca exchanger current (INCX) [31].
If the effect of INCX dominates, positive Ca - Vm coupling will occur, where a large cal-
cium causes prolonged APD by an enhanced calcium outflux through INCX. Otherwise,
when a large Ca transient reduces ICaL through increased calcium-dependent inactivation,
APD will be shortened [30]. Ca instability is another multifactorial process. The key com-
ponents are the fractional Ca release from the sarcoplasmic reticulum (SR), which refers to
the relation between the Ca released from the SR and the SR calcium load, and the cytosolic
Ca sequestration, which refers to the efficiency of Ca removal from the cytosol through the
reuptake to the SR and the outflux through the Na-Ca exchanger [32]. In general, factors
increasing fractional Ca release promote Ca alternans and factors increasing Ca sequestra-
tion reduce alternans [30]. Many studies have attributed cardiac alternans to disturbances
of calcium signaling, with APD alternans considered a secondary effect [33, 34, 35, 36,
37].
There are two types of reentry. The anatomic reentry has a fixed anatomic pathway [38].
For example, in the Wolff-Parkinson-White syndrome mentioned before, an extra electrical
pathway connects the atria and ventricles, allowing electrical impulses to bypass the AV
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(a) (b) (c) (d)
(e) (f) (g) (h)
Figure 2.4: Demonstration of functional reentry
node. When the electrical impulses use this detour through the heart, the ventricles are
activated too early [39]. In this case it develops a global anatomic reentry pathway between
the atria and the ventricles. Another typical example of anatomic reentry is a spiral wave
pinned at an unexcitable obstacle (ischemia or scar tissue for example) after a normal plane
wave passing through.
The functional reentry does not require an anatomic obstacle or pathway [40]. Instead,
the excitation waves rotate around a functional obstacle called the core of the spiral wave.
A common mechanism to generate functional reentry is through the S1-S2 pacing protocol
shown in Fig. 2.4. The protocol is composed of two beats. The first beat S1 generates a
normal plane wave (Fig. 2.4a); the second stimuli S2 is delivered at the tail of S1 (Fig. 2.4b)
and it will curve around the refractory areas created by the S1 stimuli (Fig. 2.4c) and gen-
erate a spiral. The obstacle in this situation is functional, created by the refractory period.
In Fig. 2.4 the spiral wave is self-sustainable and it will never die out.
Alternans and functional reentries are closely related. Discordant alternans increases
the vulnerability to reentry by increasing the spatial dispersion of refractoriness, thus it
makes it more likely for the next premature beat to generate reentry [28].
The reentry-based tachycardia can cause a quickly rotating spiral wave in the atria
(atrial flutter) or ventricles (VT). And fibrillation is degenerated from tachycardia when
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the spiral wave breaks into multiple wavelets [41].
2.4 Existing theory on mechanism of fibrillation and defibrillation
Defibrillation is termination of arrhythmias by altering the transmembrane voltage through
the delivery of electric shocks [41]. It has been known for over 100 years that electrical
shocks can both initiate and terminate fibrillations [42][43]. Debates on the mechanisms
behind defibrillation, however, have never ceased. Ideker et al [44] had an excellent anal-
ogy, comparing different hypotheses to “blind men feeling the elephant”: “investigators
performed their own research studying different aspects of defibrillation but no one can see
the whole picture”.
From the “minimum energy necessary in defibrillation” point of view, it has been shown
that the strength of electrical shocks can be greatly reduced. Dudel [45] hypothesized the
minimum electric field needs to paralyze the entire ventricle. Wiggers [46] proposed the
field only needs to halt the activation fronts. Zipes et al [47] and Mower et al [48] suggested
a even weaker field halting activation fronts only in a critical mass. Recently even lower
energy was proposed utilizing multiple shocks and combined stages of treatment to further
reduce the energy needed [49][50].
From the “initiation and termination of fibrillation” point of view, several hypotheses
were proposed in the 70s and 80s that associated the induction and termination of arrhyth-
mias by shocks to the same mechanisms. The “upper limit of vulnerability” hypothesis [51]
claimed the upper limit of the strength of shocks that induce fibrillations is approximately
the same as the defibrillation threshold. The “field-recovery critical point” hypothesis [52]
stated that the critical variables in both induction and termination of fibrillation are the dis-
persion of recovery and the potential gradient field. However, this hypothesis suggested
the nonuniform dispersion of refractoriness is induced by the S2 shock itself while an-
other hypothesis called the “nonuniform dispersion of refractoriness” hypothesis [46][53]
suggested the premature S2 stimuli only initiates the fibrillation, the dispersion of refrac-
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toriness is inherited from the ionic channels, conductivity and other properties in the tissue.
This “nonuniform dispersion of refractoriness” implied much smaller electrical stimuli in-
duce fibrillations from a mechanism different than strong shocks halt fibrillations.
From the 90s, optical mapping techniques using potentiometric fluorescent dyes to
record transmembrane potential changes in defibrillation shocks revealed the effect of pro-
longation of action potential by the shock followed by simultaneous AP recovery, indi-
cating simultaneous recovery through the whole myocardium after shock as essential in
successful defibrillations [54][55][56].
More recent studies suggested the contribution of inhomogeneities to depolarization
in tissues during a defibrillation shock, stating the heterogeneities, such as vessels and
bundles, serve as virtual electrodes during an electric shock, enhancing the depolarization
and hyperpolarization in tissues far away from the anode and cathode [1].
The theory of primary and secondary sources of electric field in excitable tissues can
be tracked down from Maxwell equations [57]. The primary source arises from the com-
bination of an ohmic current due to the resistivity of tissue and a nonohmic current due to
active transport, which is the movement of ions or molecules across a cell membrane into
a region of higher concentration ( ~J = σ ~E + ~J i). The secondary source arises from the
boundaries where electrical discontinuities occur. For example, on the interface between
two media with different conductivities σ1 and σ2, a current layer lies with the density of
~K = φ(σ2 − σ1)n̂, φ being the potential and n̂ being the normal vector of the surface.
Theoretical analysis using geometries and conductive properties from cardiac cells showed
that secondary sources are more significant than the primary ones [57]. These secondary
current sources will occur at any interface separating two media with different electrical
conductivities, such as the gap junction that serves as connection between two adjacent
cells, inhomogeneities in tissues like vessels and bundles, and changes in fiber orienta-
tions [58]. Due to the secondary sources provided by heterogeneities, electric field can
penetrate through tissues without dying out at the boundary exponentially. The secondary
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source is also called virtual electrode.
Experiments confirmed secondary sources on cellular levels. Fast el al [59] studied
the effect of defibrillation shocks on monolayer cells cultured with specifically designed
clefts. The results found depolarization and hyperpolarization on each side of the cleft and
a linear relationship between the strength of the secondary source and the obstacle length
but a nonlinearly increase of the source strength with respect to the strength of the shock.
Experiments also found a dog-bone shaped depolarization (or hyperpolarization region
dependent on the polarity of the stimulation) in transmembrane potential for a point-size
stimulus due to the anisotropy in cardiac tissue [60][1]. It is called a virtual electrode po-
larization (VEP) pattern. The VEP plays key role in electrical stimulation in heart and
experiment showed damaged tissue can eliminate VEP and increase the defibrillation pac-
ing threshold [61].
Several simulation studies showed the effect of fiber orientations and curvatures on de-
fibrillation shocks. Trayanova et al [58] demonstrated shock-induced electrodes associated
with fiber curvature can extinguish a recirculating spiral wave. Bittihn et al [12] showed an
optimal negative curvature for which the effect of electric filed is the largest in defibrillation
shocks, suggesting negative curvature structures such as papillary or trabecular muscles can
be employed to facilitate defibrillation.
2.5 Optical mapping and pacing protocols
Optical mapping techniques use potentiometric fluorescent dyes to record transmembrane
potential changes. Tissue is perfused with voltage (or calcium) sensitive dye, whose emis-
sion intensity shifts when transmembrane voltage changes. By recording the emitted light
intensity with a high speed camera, we can recover the transmembrane voltage signal. In
this thesis, we compare our simulation results directly with optical mapping experiments.
Here we briefly describe the procedures of the optical mapping experiments.
All experiments conform to the current Guide for Care and Use of Laboratory Animals
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published by the National Institutes of Health (NIH Publication No. 85-23, revised 1996),
and approved by the Office of Research and Integrity Assurance at Georgia Tech. Animals
(New Zealand white rabbits or Mongrel dogs) were anesthetized and euthanized. Hearts
were then quickly removed and perfused with cardioplegic solution, gassed with 95% O2
and 5% CO2. Then the hearts (for rabbits) or separated ventricle or atria (for dogs) were
immersed in a chamber kept at 37◦C and perfused with Tyrode’s solution. Tissue con-
traction was suppressed by using blebbistatin. For imaging, the heart was stained with the
voltage-sensitive dye Di-4-ANEPPS or JPW-6003 and intracellular calcium-sensitive dye
Rhod-2.
For defibrillation experiments, ventricular arrhythmias were induced by fast pacing (60-
150ms) while atrial arrhythmias were induced by applying acetylcholine before pacing
(30-65ms) [62]. Both VF and AF featured multiple spiral waves. Pacing and defibrillation
shocks consisted of rectangular pulses. For the LEAP experiments, a sequence of at least
5 pulses was applied with a 5-ms pulse duration and a cycle length 5-10 ms below or
above the dominant period of the arrhythmia. The minimum energy required to terminate
fibrillation by standard one-shock defibrillation was obtained on the same hearts.
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CHAPTER 3
COMPUTATIONAL MODEL OF THE HEART
In this Chapter, I will briefly describe computational cardiac models. I will first review the
mathematical equations that are used to model a single cardiomyocyte, then further extend
them to modeling multi-dimensional tissue from 1D cable to 3D geometry. Then I will
introduce Web Graphic Library (WebGL), a library for computation using GPU.
3.1 Cardiac cell modeling
The single cell membrane potential can be described by the following current conservation




= −Iion + Istim, (3.1)
where Cm is the membrane capacitance (unit:µF/cm2), Vm is the transmembrane voltage
(unit:mV ), Iion and Istim correspond to the membrane ionic current and stimulus current,
respectively (unit:µA/cm2). Figure 3.1 shows the circuit representation of Eq. 3.1.
Figure 3.1: Circuit representation of the membrane
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The ionic current Iion is usually a sum of several different current. Depending on the
complexity of the ionic current, single cell models can be classified into two types: elec-
trophysiological (EP) models and phenomenological models [63].
EP models try to simulate actual ionic concentrations and currents. The ionic cur-
rent is usually comprised of a large number of individual currents that represent specific
Na+, K+, Ca2+ current and are often inherited or modified from previous generations of
models [64][63][65][66]. Earlier models, known as the first generation [64][63][65], had
fixed intracellular ion concentrations with classic Hodgkin-Huxley(HH) [67] type of equa-
tions based on experimental voltage clamp data to describe their ion channels [68][69][70].
The second generation models improved on the first generation by allowing changing ion
concentrations [71][72][73]. And some more recent models, the third generation, include
more detailed mathematical descriptions using advanced multi-state Markov-chain equa-
tions [74][75][76].
One thing to note is the enormous complexity more recent models acquired, some have
multiple compartments within the cell such as the sarcoplasmic reticulum (SR) and mito-
chondria [75][77]. Including detailed subcellular processes into EP models, on one hand,
enables us to have a complete picture of cell activities, providing potential explanations
of experimental phenomenon from a subcellular point of view [75][76][77], on the other
hand, however, it greatly increases the computational cost for some models have over 50
variables [78] and the large number of parameters also greatly increases the difficulty to
understand the dynamics of the model.
Phenomenological models tend to use simple expressions to reproduce fundamental ex-
perimental characteristics without imitating actual ionic currents [63]. A frequently used
model is the FitzHugh-Nagumo (FHN) model [79]. The motivation of this model is to sim-
plify the process of representing a class of excitable-oscillatory systems. The model only
has two variables: one voltage (u) and one gating (v) variable; they represent excitability
and refractoriness respectively. Other phenomenological models include Rogers-modified
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FitzHugh-Nagumo model [80] and Fenton-Karma model [81]. Due to its simplicity, phe-
nomenological models of cardiac cells are often coupled to produce higher dimensional
tissues. The downside of phenomenological models is that they are usually too simple to
produce some complicated dynamics.
Single cell models usually only involve ordinary differential equations (ODE) with time
(t) being the independent variable. ODE solvers with various orders of accuracy such as
forward Euler (1st order), backward Euler (2nd order) and Runge-Kutta (4th order usually)
are commonly used [82]. The Rush-Larson method is used to improve the stability of
integrators such as the forward Euler [83].
3.2 Tissue modeling
Cardiac cells are connected through gap junctions, which allow molecules and ions to pass
through so the electrical signals can propagate from cell to cell. The propagation of action




= 5 · (D5 Vm)− Iion + Istim (3.2)
This equation is like Eq. 3.1 with an addition of the term 5 · (D 5 Vm), which is used to
model the diffusion (propagation) of the transmembrane voltage through the tissue. The
boundary condition is n̂ · (D 5 Vm) = 0. Figure 3.2 shows a schematic circuit diagram
for Eq. 3.2 in a 1D case. The intracellular space is modeled with resisters in series and the
extracellular potential is grounded.
Equation 3.2 only models the transmembrane potential, assuming the potential of the
extracellular space is proportional to the potential of the intracellular space, scaled by the
conductivities. This assumption is true if the ratio of conductivities parallel and perpendic-
ular to the fibers is the same in the intracellular and extracellular space [63]. In a 1D cable,
this assumption is automatically satisfied because there is only one direction. This equation
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Figure 3.2: Circuit representation of the monodomain model
is also called the monodomain model. In higher dimensions, experimental results showed
this ratio in intracellular domain is usually five times that of the extracellular domain for
cardiac tissues [84]. If the anisotropy is not important to the study, monodomain model
is sufficient. Otherwise bidomain models need to be used. Bidomain models simulate
potentials in both the intracellular and the extracellular domain (Figure 3.3):
Cm∂Vm/∂t = −Iion +∇ (Di∇Vm) +∇ (Di∇Ve) (3.3a)
∇ (Di∇Vm) +∇ ((Di +De)∇Ve) = 0 (3.3b)
where Vi and Ve are the intracellular and extracellular potentials, the membrane potential
is given by Vm = Vi − Ve, and the intra- and extracellular diffusions are given by Di and
De.
Traditionally, defibrillation simulations require using bidomain models due to the effect
of electric field on conductive heterogeneities that we mentioned in the previous Chapter.
Figure 3.4 demonstrates the bidomain circuit with unexcitable gap in the intracellular do-
main (heterogeneity). When external electric shock is applied, current will flow from the
anode to cathode in the extracellular space. It will enter the intracellular space when it
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Figure 3.3: Circuit representation of the bidomain model
Figure 3.4: Circuit representation of the effect of electric field on unexcitable gaps in the
intracellular space
reaches the intracellular boundary and it will be forced to flow outside of the intracellular
space when it reaches the unexcitable gap, which will create repolarization and depolar-
ization of the transmembrane potential at those two sites and secondary sources can be
produced at the depolarization sites. Traditional monodomain model will not be able to
reproduce that.
Recently Pumir et al [85] proposed using monodomain equations with appropriate
boundary conditions for simulating the effect of external electric field on heart tissue. In
the presence of an external electric field, E0, at both the domain boundary and the interface
between two conduction discontinuities, the boundary condition reads [85]:
n̂ · (5Vm −E0) = 0 (3.4)
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(a) Monodomain (b) Bidomain
(c) Difference between bidomain and
monodomain
Figure 3.5: Comparison of the transmembrane potentials under the steady-state electric
field on the 2D domain between monodomain and bidomain simulation. (a) Monodomain
steady state (b) Bidomain steady state (c) The difference between the bidomain and the
monodomain.
By using this boundary condition, the monodomain model can generate secondary
sources at the conduction heterogeneities. Figure. 3.5 shows the transmembrane poten-
tials on a 2D domain with an unexcitable square (heterogeneity) under a constant electric
field, solved from the monodomain equation (Fig. 3.5a), bidomain equation (Fig. 3.5b), and
Fig. 3.5c shows the difference between the bidomain and the monodomain. We can see that
the monodomain and the bidomain models produce similar results. I used the monodomain
equations with Pumir’s boundary conditions for most part of this thesis.
Equation (3.2) is a parabolic equation which contains first order derivative in time and
second in space. Finite difference solvers for parabolic equations based on Taylor expan-
sions include forward Euler (first order accuracy in ∆t and second in ∆x), backward Euler
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and Crank-Nicolson method (second order accuracy in both ∆t and ∆x) [82]. In this thesis,
I used the forward Euler solver with the Rush-Larson method.
3.3 Accelerating simulation with WebGL
To obtain reliable defibrillation results that can shed light on the mechanism of fibrillation
and defibrillation and provide guidance for future experiments, we need to run realistic
simulations, with respect to both the ionic model and the geometry of the heart. Running
complex cardiac models on realistic heart geometry with sufficient resolution is computa-
tionally costly.
Graphic Processing Units (GPUs) can provide high levels of parallelization. Each GPU
contains thousands of cores, which can perform calculations of each computational element
simultaneously. There are many GPU programing languages. In my work, I used WebGL
to accelerate defibrillation simulations.
WebGL (web graphic library) is a JavaScript API for rendering interactive 3D and 2D
graphics within any compatible web browser. It’s fast speed, free, and independence of
operating systems.
The essence of WebGL programing is the implementation of ”Fragment Shader”. A
fragment shader is a part of the WebGL application that is in charge of coloring each pixel
on a surface using four values: red (r), green (g), blue (b), and transparency (α).
For example, if I would like to simulate FitzHugh-Nagumo [79] model on a 100 by
100 square domain, I can define a canvas with the size of 100 by 100. For each pixel on
the canvas, I assign its ”red” value to represent the membrane voltage (u) and assign the
”green” value to represent the refractory gate (v). The algorithm for solving the PDE of u




CALCIUM DYNAMICS AND CONTRACTION
4.1 Motivation for this chapter
Electrical stimulation such as cardiac resynchronization therapy (CRT) and cardiac contrac-
tility modulation (CCM) have shown success in treating patients with heart failure (HF) [86,
87]. CRT is a current treatment for patients with congestive heart failure (CHF) for a wide
QRS complex, where biventricular pacemakers are used to improve electrical synchrony
and presumably ejection fraction [86, 88]. However, the response to CRT varies greatly
among patients. Improvements are quite variable with up to 30% of patients being non-
responders to this treatment at all [86, 89]. Nevertheless, the efficacy and optimization of
CRT continues to being improved [90, 91]. For example, it has been shown that extensive
electrical remodeling is significantly associated with better survival rates after CRT [90].
Other measurements than electrical dyssynchrony have been investigated as identifications
for CRT implantation estimation. It has been suggested that mechanical dyssynchrony is
as well essential in prediction of CRT response [91]. An alternate electrical therapy for HF
is cardiac contractility modulation (CCM) which delivers electric fields to the heart during
its refractory period. Although its mechanism of action was initially thought to result from
increased calcium flux from Sarcoplasmic Reticulum (SR) [92, 87], recent studies suggest
this is not the case, but that increased contractile function is the result of β adregenergic
stimulation [93]. Clinical studies have showed that CCM therapy improved quality of life,
exercise capacity, New York Heart Association (NYHA) class, and ejection fraction (EF)
during long-term follow up [94]. However, other clinical studies have reported contradic-
tory evidence where CCM did not change effects on hospitalization or mortality [95], and
it did not increase myocardial oxygen consumption [96]. It is clear then, that optimization
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of CRT and CCM therapies require an understanding of the effects of electric fields on my-
ocyte dynamics especially for inotropicity as regulated by intracellular calcium. Computer
simulations have the potential to improve these therapies through clarification of the un-
derlying mechanisms [97]. For example, one challenge in CRT is to determine the optimal
pacing locations; Miri et al. provided an optimization strategy to find the best pacing sites
and timing delays in CRT based on biventricular-paced activation sequences and ECGs ob-
tained from simulations using patient-specific anatomy and pathophysiology models [98].
Computer simulations can also be beneficial to help to predict the response of patients to
certain therapies [99, 100]. For instance, Niederer et al. have designed an electromechan-
ical heart model based on clinical observations [101]. The model predicted that patients
with dyssynchronous electrical activation but effective length-dependent tension regulation
at the cellular scale are less likely to respond to CRT treatment than patients with attenuated
or no length dependent of tension.
Such simulations of electrical therapy require a robust model of cellular excitation-
contraction coupling that occurs in the cardiac myocyte such that the electrical and con-
traction predictions are both accurate. From the introduction to the intracellular calcium
handling in Chapter 2, we can see that calcium is deeply involved in two highly non-linear
systems: the electrical activation and the force generation. Calcium binding with troponin
C is the key component linking the electrical signals to the activation of tension.
While there are close to a hundred cell models describing the detailed electrophysiology
(EP) of cardiac cells, the majority of cell models do not include the equations to reproduce
the contractile force [102, 103]. This is a considerable drawback. In this Chapter, I first
introduce a protocol for testing contraction behaviors, then I prescribe a systematic method-
ology to implement contraction into EP models. Then I evaluate the contraction behavior of
14 models and conclude with the criteria for EP models that are most suitable to implement
contraction. Table 4.1 listed all the terminology used in this chapter.
While there are close to a hundred cell models describing the detailed electrophysi-
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ology (EP) of cardiac cells, the majority of cell models do not include the equations to
reproduce contractile force[19,20]. This is a considerable drawback. We suggest the most
appropriate and challenging test for Electrical-contractile coupled (ECC) cell models de-
rived from EP models is to reproduce the ”postextrasystolic potentiation” (PESP) behavior
of the heart [104]. PESP is an example of the changes in stimulation pattern on contractile
strength. The effect can be demonstrated with the PESP pacing protocol [105]. First, a
train of stimuli is delivered with a fixed basic cycle length called the priming period (PP).
Second, an extrasystolic (ES) beat is delivered after the last priming stimulus by an interval
called extrasystolic interval (ESI). Following the ES beat, a postextrasystolic (PES) beat is
then delivered after another interval called the postextrasystolic interval (PESI). In normal
hearts the strength of postextrasystolic contraction is a function of both ESI and PESI. If
ESI is fixed, postexatrasystolic strength increases as PESI is lengthened. If PESI is fixed,
postextrasystolic strength increases as ESI is shortened. This effect includes mechanical
restitution and pause dependence and it captures the important heart dynamics involving
force generation and calcium cycling that occurs over multiple beats. Just like the elec-
trical restitution protocol is a stringent test for electrical rate dependence, we believe that
reproducing the PESP protocol is essential for an electromechanical cell model. In contrast
to electrical restitution in which action potential duration is recorded for a single extrasys-
tolic beat, the purpose of the PESP protocol is to study the contractile strength as a function
of a single extrasystolic followed by a compensatory pause. The idea is to capture the full
cycle Ca handling, specifically the release of calcium from the SR as a function of timing
and the dynamics of the restoration of releasable SR during (and following) action potential
repolarization. The basic theory lies in the fact that release from the SR is determined by
two factors: the recovery of Ryanodine Receptor’s (RyR’s) which is a function of interbeat
interval; and the amount of Ca in the SR. When ESI>PP, RyRs are more recovered from the
last priming beat, resulting in a bigger Ca release from SR for the ES beat. Consequently,
the Ca content in SR will be smaller compared to the priming period, and may lead to a
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smaller or larger Ca release (compared to PP) for the next PES beat depending on the PESI.
In this chapter, we first present a systematical methodology to incorporate mechanical
models into various existing EP models. We chose fourteen of the most recently developed
EP models with multiple cellular compartments, advanced ionic currents and more real-
istic subcellular dynamics because they include the essential elements required to couple
contraction models (e.g., SR dynamics and calcium buffers). We studied these models un-
der the isometric condition by 1) evaluating how their calcium dynamics are affected by
the inclusion of the contraction and 2) assessing how well these electromechanical models
simulate contraction by comparing their PESP contractile response with experiments from
Yue et al. and 3) analyzing the mechanism of PESP by finding the correlation between the
calcium release from SR and the contractile strength. Finally we concluded with insights
regarding the suitability of various models to reproduce electromechanical activities and
the underlying mechanism of PESP, which may provide guidelines for future experiments.
4.2 Methods
In this section we introduced the contraction model that we implemented to EP models and
the experiment we compared our simulations to, then we described our classification of EP
models and corresponding strategy for contraction implementation, the numerical methods
used to solve the models as well as the pacing protocols and data analysis.
4.2.1 The contraction model
We chose the Negroni Lascano 1996 (NL96) [106] contraction model to represent the cou-
pling of cross-bridge dynamics and intracellular calcium kinetics. The muscle unit structure
and cross-bridge dynamics are shown in Figure 4.1.
The muscle unit is composed of an inflexible thick filament (myosin), a thin filament
(actin) and an elastic paralleled element (titin). The cross-bridges are attached to the thick
element on one end and can slide on the thin element on the other end. The total force is
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Figure 4.1: Muscle unit structure
contributed by two parts: force generated from the elastic element (Fp) and force generated
by the cross-bridges (Fb):
F = Fb + Fp (4.1a)
Fp = K(L− L0)5 (4.1b)
Fb = A([TCa
∗] + [T ∗])h (4.1c)
whereK, A and L0 are constants; L is the sarcomere length; [TCa∗] and [T ∗] are two states
associated with troponin C sites on the thin filament (defined below); h is the elongation of
the muscle unit. The fifth order nonlinear term in Fp is due to the simplification to avoid
discontinuity in the representation [106]. For ”isometric” contraction where the sarcomere
length is fixed, Fp is constant, and the total force is determined only by the force generated
from the cross-bridges. We study the isometric case because for a physiological work-loop
styple contraction, the first phase is isovolumetric contraction. Cross-bridge grabbing and
sliding on the thin element will generate force Fb, which is proportional to the elongation
(h) and the total number of attached cross-bridges. The number of attached cross-bridges
is determined by the interaction with Ca2+ and the relevant buffers, which is represented
by a four-state system comprised of:1) sites on the thin element with free troponin C ([T ]);
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Figure 4.2: Transition among the four states
2) sites with Ca2+ bound to troponin C ([TCa]); 3) sites with Ca2+ bound to troponin
C and attached cross-bridges ([TCa∗]); and 4) sites with troponin C not bound to Ca2+
but attached cross-bridges ([T ∗]). The transitions happen among these four states via the
binding and releasing of Ca2+ and attaching and detaching of cross-bridges (Figure 4.2).
The number of total cross-bridges is the sum of the two states that associated with cross-








2+]i[T ]− Z1[TCa])− (Y2[TCa]eff − Z2[TCa∗]) (4.2b)
d[TCa∗]
dt
=− (Y3[TCa∗]− Z3[T ∗][Ca2+]i) + (Y2[TCa]eff − Z2[TCa∗])
− Yd(dX/dt)2[TCa∗] (4.2c)
[T ] =[Troponin]total − [T ∗]− [TCa]− [TCa∗] (4.2d)
These are reaction equations among the states of [T ], [T ∗], [TCa], and [TCa∗]; all with
units of mM/ms. [TCa]eff is the effective [TCa] where cross-bridge attachment can occur
and its dependent on the sarcomere length (see Eq. (10) in [106]). X = L − h, which is
the inextensible length in the muscle unit. Y1 ∼ Y4, Z1 ∼ Z3 and Yd are rate constants.
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The NL96 model includes feedback from force on [Ca2+]; therefore it is, in general, a
”strongly coupled” contraction model, but under isometric condition it is weakly coupled
since dX/dt = 0 [66].
There are three reasons why we chose the NL96 model. First, it shares common el-
ements with the EP models; this greatly simplifies the implementation procedure. For
example, the four states in the Ca2+ kinetics are closely related to intracellular Ca2+ con-
centration and Troponin concentration, both of which are common elements in advanced
EP models. Second, even though NL96 model is a simplified model of the average effect of
the interaction between myosin and actin, it can effectively reproduce basic physiological
findings, such as time course of isometric force, intracellular Ca2+ transient and force-
length-Ca2+ relation. Third, our method to incorporate NL96 can be easily applied to
other contraction models as long as they use ODEs to describe the Ca-Troponin (CaTRPN)
states, like [107, 108, 109].
4.2.2 The contraction experiments
We implemented contraction into 14 electrophysiology models. To evaluate the ability of
these fourteen models to reproduce experimental findings, we compared the results of the
simulations with the isovolumetric canine ventricular experiments from Yue et al. [105].
We chose Yue et al. because their paper includes not only a comprehensive experimental
exploration of the relation between the contractile strength and pacing intervals, but also
a concise mathematical framework that allows quantitative comparisons of model predic-
tions.
We applied the same PESP pacing protocol employed by Yue et al. [105], which was
introduced in the Introduction section. By fixing ESI and varying PESI, Yue et al. [105]
measured the rate of pressure change of the PES beat as a function of PESI; then by chang-
ing ESI to another value and repeatedly varying PESI, a family of curves can be constructed
showing the effect of both ESI and PESI on pressure change. Figure 4.3 shows an example
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Figure 4.3: Contractile characteristic curves generated from equations in Yue experiments:
(a) Postextrasystolic mechanical restitution curves (MRCpes) using ESI equal to 300ms
(solid line), 350ms (dash line), 460ms (dash-dot line) and 1200ms (dot line). (b) Postex-
trasystolic potentiation curve (PESPC, dash line) and extrasystolic mechanical restitution
curve (MRCes, solid line).
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of the results from Yue et al. [105].
In Yue’s experiments, they measured the maximum rate of pressure change in four-
teen isolated perfused left canine ventricles under the isovolumetric conditions. In the
NL96 contraction model, force (normalized to muscle cross section area) is the variable to
quantify the contractile strength; therefore to correlate with Yue’s experiment results, we
assumed a linear relationship between the force generated from a single cell and the ven-
tricular pressure [110], thus we compared the normalized maximum rate of force change in
our simulations with the normalized maximum rate of pressure change in Yue’s paper.
4.2.3 Ventricular models and electrophysiological contraction implementation
We studied fourteen ventricular cell models, which include four species: guinea pig (n=4) [76,
111, 112, 113], rabbit (n=2) [114, 115], dog (n=2) [116, 117] and human (n=6) [118, 78,
77, 119, 120, 121]. We classified the models into five categories based on the type of their
calcium buffers and designed corresponding strategies to implement NL96. The complexity
of the implementation of contraction into these five types of models is listed in ascending
order. The flowchart 4.4 illustrates steps of the implementation. We provide the essen-
tial equations, initial conditions and choice of parameters below. Table 4.2 lists general
information about all models including classification, species, buffer information, number
of variables, stimulus current amplitudes and durations; rate constants for CaTRPN can be
found in Table 4.3.
Type One: models with contraction
Two of the fourteen models have contraction in their original versions: Iribe etal 2006 [111]
and Matsuoka etal 2003 [76]. Matsuoka etal 2003 already has NL96 contraction in the
original version. However, to investigate how much influence the contraction has on this
model, we removed the NL96 model (the four-state variable dynamic buffer as in Eq. (4.2))
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Figure 4.4: Flowchart of systematically implement contraction into EP models
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2+]i(Bmax,trop − [CaTRPN ])−Koff [CaTRPN ] (4.3)
[Ca2+]i is the intracellular Ca2+ concentration; Bmax,trop is the total Troponin concentra-





We set Kon and Koff to the values of Y1 and Z1 and Bmax to the value in the original
model. We call this new model Matuoska etal 2003 without Contraction. Iribe etal 2006
includes the contraction model of Rice et al. (RWH99) [107] in the original version [111].
For RWH99, CaTRPN is expressed by a single-state dynamic equation like Eq. (4.3) but
with a dynamic rate constant Koff that depends on force, hence it is strongly coupled
even for isometric contractions. Also the RWH99 model has six tropomyosin/cross-bridge
states with rate constants that are functions of the CaTRPN concentration. To simulate this
model without contraction, we eliminated the six tropomyosin/cross-bridge states and set
Koff for CaTRPN to a constant value by fixing the force in the Koff expression to half of
its maximum value. We then compared simulations of the original model and the version
without contraction as well as the one with the NL96 contraction model (implemented as
described in the next ”Type Two” section).
Type Two: models with full dynamic buffers
Two of the models incorporate ordinary differential equations (ODEs) for all the buffers:
Shannon etal 2004 [114] and Grandi etal 2010 [118]. The equations for the original CaTRPN
in these models are the same as Eq. (4.3). For models of Type Two we added the four-state
NL96 model using Eqs. (4.2) above; this is done by splitting the dynamical CaTRPN in the
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and adding the other two states T and T ∗. There are multiple Kon and Koff in Eqs. (4.2).
They are kept the same as original NL96 paper [106] except for Y1 andZ1, which are chosen
to match the values of Kon and Koff in Eq. (4.3) from the original model (see Table 4.3).
This is to preserve the dynamics of Ca as similar as possible to the original model.
Type Three: models with dynamic CaTRPN
Two of the models use ODEs for CaTRPN but instantaneous forms for all the other buffers:
Mahajan etal 2008 [115] and Iyer etal 2004 [78].
For this type of models we followed the same step regarding the dynamic CaTRPN
in Type Two above and kept all the other buffers instantaneous. The only difference be-
tween Type Three and Type Two is that there are instantaneous buffer factors in Type Three
models (see Eq. (4.6) below) but not in Type two.
Type Four: models with instantaneous CaTRPN
Five of the models have instantaneous CaTRPN: Hund etal 2004 [116], Faber etal 2000 [112],
Livshitz etal 2007 [113], Ohara etal 2011 [77] and Priebe etal 1998 [119]. The buffering










ICatotal is the total intracellularCa
2+ current; β is the instantaneous buffer factor; index j rep-
resents each type of intracellular Ca2+ buffer; Bmax,j and Kd,j are the total concentration
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and the affinity constant for buffer j. For this type of model we first changed the instanta-
neous intracellular CaTRPN into a dynamic buffer by eliminating the CaTRPN term from






= β′(ICatotal − ICaTRPN) (4.7a)










2+]i(Bmax,trop − [CaTRPN ])−Koff [CaTRPN ]
(4.7c)
in which j′ goes through all Ca2+ buffers except for CaTRPN. The way to choose Kon and
Koff here is not unique as long as
Koff
Kon
= Kd in the original model. We chose Koff =
√
σKoff,s and Kon = 1/
√
σKon,s, where the subscript ’s’ indicates the values from the
Shannon etal 2004 model and σ = Kd
Kd,s
. We used the values from Shannon etal 2004 as
the standard values here because they have been widely used to simulate dynamic CaTRPN.
After changing the instantaneous CaTRPN into a dynamical buffer, we followed the same
procedure as for Type Three models to incorporate the NL96 contraction.
Type Five: models without Ca troponin buffers
Three of the models do not have CaTRPN, but they do have other intracellular Ca2+
buffers: Fox etal 2002 [117], TenTusscher etal 2006 [120] and Fink etal 2008 [121].
For this type of models, we first added the instantaneous CaTRPN into the models. If
the model has one general Ca2+ buffer (referred as ”General”) representing the average
effect of all intracellular Ca2+ buffers (e.g. TenTusscher etal 2006 and Fink etal 2008),
we split the general buffer into two parts: CaTRPN and ”Other”. We kept Kd,TRPN and
Kd,Other to be the same as Kd,General from the original model so that the Ca affinity of
the instantaneous buffer will be retained. Bmax,TRPN was set to be 0.07mM, which is
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a standard value in most models. Bmax,Other = Bmax,General − Bmax,TRPN so that the
concentration of the total intracellular Ca2+ buffer is the same as in the original model. If
the model has other Ca2+ buffers (such as CMDN) but no CaTRPN (e.g. Fox etal 2002),
we kept the other buffers unchanged and add a CaTRPN buffer. For the new CaTRPN buffer
we also set Bmax,TRPN = 0.07mM and Kd,TRPN = 0.6µM , which are both common
values in many models. After adding an instantaneous CaTRPN to the model, we followed
the steps for Type Four to implement NL96.
4.2.4 Numerical integration
Except for one model (Iyer etal 2004), all the code for the original single cell models were
downloaded from www.cellml.org in CELLML format. Then they were translated into
.m files (MATLAB files) using a PYCML program [122, 123]. Simulations were run in
MATLAB and integrated using the forward Euler integration method with time steps of
0.0001ms. The Iyer etal 2004 model consists of 67 variables and requires a dt integration
step as low as 1 × 105 to converge using forward Euler, thus becoming impractically slow
to simulate in MATLAB. Therefore as in [124] the Iyer etal 2004 model was written in
FORTRAN using a semi-implicit integration method that allows a much larger (while still
convergent) integration time step of dt.
4.2.5 Pacing protocol and initial conditions
Our pacing protocol is composed of three steps and similar to the pacing protocol from Yue
et al [105] except that we chose to use a priming period of 500ms. The stimulus currents
and durations for the different models were selected to ensure excitation and the values are
provided in Table 4.2. All simulations were run for isometric contraction of a single cell,
where the half sarcomere length is fixed to be 1.05µm.
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Step one: Quiescent
In this step, EP models without contractions were run with no stimulus current until quies-
cent steady states were reached (i.e., no state variable changed by more than 0.01%). Initial
values for state variables in each model were directly loaded from CellML code. The time
for each model to reach the quiescent state is listed in Table 4.3, and it ranges from 10min
of real time (as in the Mahajan etal 2008 model) to up to 100min (as in the Hund etal 2004
model). Note that these are real times and not simulation times. Steady state quiescent val-
ues for voltage, intracellular Ca2+ and JSR (or SR) Ca2+ concentrations vary considerably
among models as shown in Table 4.4.
Step Two: Priming Cycle
During the priming pacing cycle, all models (with and without contractions) were paced
with priming period T=500ms starting from the quiescent states at the end of Step one,
until a new priming steady state was achieved. The number of pacing required to reach this
priming steady state for each model is listed in Table 4.2. For models incorporating NL96
contraction, state variables for the four states of CaTRPN buffer were calculated by solving
Eqs. (4.2) for steady state using the quiescent value of [Ca2+]i. The total CaTRPN buffer
(TCa + TCa∗) calculated using this method was verified to be similar to the quiescent
value in the original EP model if the original model had a CaTRPN buffer. We used this
method to ensure that the initial conditions for the original models and the corresponding
contraction models were as close as possible.
Step Three: Postextrasystolic pacing protocol
For all models, an extrasystolic (ES) and a postextrasystolic (PES) beat were delivered in
sequence after the last priming beat as described in Section 4.2.1. We held ESI at a con-
stant value and varied PESI to record the transients of transmembrane potential, [Ca2+]i,
CaTRPN and generated force; we then changed ESI to a different value and repeated the
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process using the priming steady state as initial conditions. The shortest PESI is the re-
fractory period of the ES beat so it is just long enough that the PES beat is separated from
the ES beat. The longest PESI (ESI) value was chosen as 1200ms, 1500ms or 2000ms,
depending on the time it took for the MRCpes (MRCes) to converge to a plateau level, as
some models took longer than others to reach it.
4.2.6 Data Analysis
Our analysis is divided into two parts: Ca2+ dynamics and Contraction.
To analyze the calcium dynamics we compare the intracellular Ca2+ transients for the
priming beats and during postextrasystolic potentiation between the original models and
models with contraction. The purpose is to see how much change there is in the calcium
dynamics after contraction is implemented. For example, we do not want to completely
distort the calcium transient after implementing contraction.
To analyze Contraction we generate four characteristic contraction curves: Postex-
trasystolic Mechanical Restitution Curve (MRCpes), Postextrasystolic Potentiation Curve
(PESPC), Minimum-value Axis Intercept Curve (to,pes plotted vs ESI) and Time Constant
Curve (Tmrc,pes plotted vs ESI). These curves capture important characteristics of contrac-
tion responding to pacing intervals. Yue et al. paper [105] has a complete description of
the definition. We validate the contraction behaviors of our model by comparing the curves
with the experiments.
For the curve fitting we used MATLAB’s built-in function ”fit”, whose default curve
fit algorithm is the Trust-Region method. The value of r2 was given for each fit and 95%
confidence bounds were provided for each fitted coefficient.
Ca2+ Dynamics
Priming Ca2+: For each model, we plotted the intracellular Ca2+ of the last priming
beat, i.e. priming steady state, for both the original model and the one with contraction
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implemented in the same plot. We quantified the transient by calculating the follow-
ing: 1) minimum (diastolic) [Ca2+]i ; 2) maximum (systolic) [Ca2+]i ; 3) the duration
for which [Ca2+]i was above its half amplitude level, i.e. [Ca2+]i > [Ca2+]diastolic +
([Ca2+]diastolic + [Ca
2+]systolic)/2 ; 4) the time at which [Ca2+]i reached its maximum
systolic value (tpeak); and 5) the amplitude of the total Ca2+ charge delivered to the cy-
toplasmic compartment during one beat (Q) that was calculated by integrating the area
underneath the [Ca2+]i + [Ca2+]diastolic transient. We quantified the difference of the pa-
rameter between the original model and the model with contractions by the relative differ-
ence, defined as ∆Parameter = (Pwith contraction−Pwithout contraction)/Pwithout contraction.
Postextrasystolic Potentiation in [Ca2+]i: For each model, we plotted the intracellular
Ca2+ transient for the last 3 priming beats, along with multiple ES/PES beat pairs overlaid
on the same graph for each model (without contraction on the left and with contraction of
the right).
Contraction
Following the data fitting and analysis from Yue paper [105] with modification, we gen-
erated four characteristic curves for each model after the implementation of contraction:
Postextrasystolic Mechanical Restitution Curve (MRCpes), Postextrasystolic Potentiation
Curve (PESPC), Minimum-value Axis Intercept Curve (to,pes plotted vs ESI) and Time
Constant Curve (Tmrc,pes plotted vs ESI).
Postextrasystolic (PES) Mechanical Restitution Curves (MRCpes) are a family of
curves of maximum force change rate of postextrasystolic beats normalized to the last
priming beat plotted vs PESI. For a fixed ESI, MRCpes increases monoexponentially to a














where F denotes the force generated from NL96 model; PES denotes that it is the postex-
trasystolic beat; SS denotes the steady state during the priming period; CRmax,pes is the
plateau amplitude, termed as Maximum Postextrasystolic Contractile Response; C0 is the
minimum value of MRCpes, in Yue et al. [105], C0 = 0; to,pes is the minimum-value axis
intercept where MRCpes intercepts the minimum value line MRCpes = C0 ; and Tmrc,pes
is the time constant for MRCpes. All terminology can be found in Table 4.1. Figure 4.3
shows one set of MRCpes generated using equations and parameters in Yue et al. [105].
Extrasystolic (ES) Mechanical Restitution Curves (MRCes) presents the maximum
rates of change of force of extrasystolic beats normalized to the last priming beat as a func-
tion of ESI. Since it is a subset of MRCPES with ESI equal to the priming cycle length,
we did not present them separately.
Postextrasystolic Potentiation Curve (PESPC) is the maximum postextrasystolic con-
tractile response (CRmax,pes) plotted vs ESI. CRmax,pes is the plateau amplitude of the
above MRCpes for a fixed ESI and this amplitude decreases to a plateau value as ESI in-
creases. Figure 4.3 shows the PESPC and the simultaneously determined MRCes, both
generated from the equations in Yue et al. [105]. The equation for PESPC fitting is:








where B is the plateau level; A is the amplitude; to,es is the ESI-axis intercept for the
simultaneously determined Extrasystolic Mechanical Restitution Curve; Tpespc is the time
constant for PESPC.
4.3 Results
The Results section is divided into three parts: Calcium Results, Contraction Results, and
the Underlying Mechanism for PESP. In the Calcium Results section we first compared
the Priming Ca2+ transients between the original EP models and the corresponding mod-
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els with the NL96 contraction to investigate the influence of including contraction on EP
models. Then we studied the Postextrasystolic Potentiation behavior in intracellular Ca2+
before and after the implementation of contraction. In the Contraction Results section
we compared the four characteristic contractile curves with the Yue et al. experiments. In
the Underlying Mechanism for PESP section we analyzed the mechanism of PESP by
finding the correlation between the calcium release from SR and the contractile strength.
4.3.1 Ca2+ Results
Priming Ca2+ properties are undisturbed after the implementation of contraction for mod-
els with dynamic buffers
We present the priming Ca2+ data in Figure 4.5, Table 4.5, Table 4.6, Table 4.7 and Sec-
tion B.1 in Appendix B. Figure 4.5 illustrates Ca2+ transients for the last priming beat for
six representative models with (dashed lines) and without (solid lines) contraction. They
are chosen to include five of the different EP types: (a) Matsuoka etal 2003 (Type One:
with contraction (NL96)); (b) Iribe etal 2006 (Type One: with contraction (RWH99)); (c)
Shannon etal 2004 (Type Two: full dynamic Ca2+ buffers); (d) Mahajan etal 2008 (Type
Three: dynamic CaTRPN); (e) Ohara etal 2004 (Type Four: instantaneous CaTRPN); (f)
TenTusscher etal 2006 (Type Five: no CaTRPN). The corresponding plots for all the four-
teen models are provided in Section B.1 in Appendix B. The five quantities computed
to quantify the priming Ca2+ transient for all EP models without (with) contraction are
provided in Table 4.5 (Table 4.6) and the relative differences between before and after con-
traction are shown in Table 4.7, where double dagger symbols (‡) indicate the differences
larger than 50%; single dagger symbols (†) indicate differences larger than 10% but less
than 50%.
[Ca2+]i differs substantially among the original EP models (without contraction) as
shown in Table 4.5. For example, for systolic [Ca2+]i, Grandi etal 2010 and
Shannon etal 2004 have values in the [0.3, 0.5]×10−3 mM range while Faber etal 2000
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Figure 4.5: Priming Ca2+ transient for six representative models: (a) Matsuoka etal 2003
(Type One: with contraction (NL96)); (b) Iribe etal 2006 (Type One: with contraction
(RWH99)); (c) Shannon etal 2004 (Type Three: with full dynamic calcium buffers);
(d) Mahajan etal 2008 (Type Three: with dynamic calcium troponin buffer) ; (e)
Ohara etal 2011 (Type Four: with instantaneous calcium troponin buffer) ; (f) TenTuss-
cher etal 2006 (Type Five: with no calcium troponin buffer). Solid lines are models with-
out contraction; dash lines are models with NL96 contraction. All figures have the same
ranges in x and y axis. The insets show the relative difference in systolic Ca2+ between
models with contractions and without contractions.
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is up to four times larger at 2.0 × 10−3 mM; for diastolic [Ca2+]i, the maximum value
is 2.0 × 10−3 mM for Faber etal 2000 and the minimum value is 3.82 × 10−4 mM for
Grandi etal 2010, which is one fifth of the maximum value.
The original models that include dynamic CaTRPN buffers (Type One to Three) do not
exhibit a significant change in the shape of the priming Ca2+ transient after implementing
contraction (adding NL96 model), but the models with instantaneous, or no CaTRPN (Type
Four and Five), demonstrate large differences in the transient shape (Figure 4.5).
The most significant changes tended to be an increase in the maximum [Ca2+]i, al-
ways accompanied by a decrease in the time of this peak (tpeak). As shown in Table 4.7,
all six models with dynamic CaTRPN have relative differences of less than 10% in sys-
tolic [Ca2+]i and five out them have relative differences less than 10% in tpeak. On the
other hand, among the eight models with instantaneous or none CaTRPN, six models show
differences larger than 50% and none has a difference less than 10% in systolic [Ca2+]i;
in tpeak, one of the eight models (Fink etal 2008) has a relative difference less than 10%
and three of them have differences of more than 50%. In addition, except for one model
(Fox etal 2002), all of them have positive relative differences in systolic [Ca2+]i, indicat-
ing a systolic [Ca2+]i increase after the implementation of the NL96 contraction; and all
eight models have negative ∆tpeak, meaning the time of the peak is decreased by the im-
plementation of contraction. The increase in maximum [Ca2+]i and the decrease in tpeak in
models with instantaneous or none CaTRPN after the implementation of NL96 is due to an
increased and fast rate change of the intracellular calcium after its dynamics has been mod-
ified from Eqs. (4.6) (before the implementation) to Eqs. (4.7) (after the implementation) to
account for the contraction. Figure 4.6 shows, as an example, the [Ca2+]i and d[Ca2+]i/dt
respectively for the Ohara etal 2011 model before (solid lines) and after (dashed line) the
NL96 implementation. It can be seen that after the implementation of NL96: (i) the instan-
taneous buffer factor β increases due to the elimination of the instantaneous CaTRPN from
the denominator (see Eqs. (4.7)); and (ii) the current ICatotal is reduced due to the addition of
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the negative dynamic CaTRPN current (see Eqs. (4.7)). The current ICatotal decreases by less
than 50% of the original value but β increases by more than 200% (Figure 4.6) resulting
in an sharp increase in [Ca2+]i amplitude. And the time for β to reach its peak is clearly
shortened, resulting in the decrease of Ca2+ peak (tpeak).
Results for the priming [Ca2+]i duration (t1/2) are similar to those of systolic [Ca2+]i
(see Table 4.7). All six models that have dynamic CaTRPN show little change in t1/2
(less than 10%). Among the eight models with instantaneous or no CaTRPN, six have
differences more than 50% and none has a difference less than 10%. Seven out of eight
have negative ∆t1/2, indicating the shortening in the time duration when [Ca2+]i stays
above half the amplitude. This large difference in t1/2 is closely related to the change in
systolic [Ca2+]i. A sharp increase in systolic [Ca2+]i greatly raises the half amplitude
level; this together with the large and narrow spike in [Ca2+]i generated by the inclusion
of contraction, significantly decrease the time duration where [Ca2+]i stay above the half
amplitude level.
The diastolic [Ca2+]i and the [Ca2+]i charge (Q) during one beat are the two param-
eters that do not change much after implementing NL96 contraction in all of the models.
Thirteen out of fourteen models have diastolic [Ca2+]i changes of less than 10%, with only
one model having a difference larger than 50% (Fox etal 2002). Q for eleven out of four-
teen models changes by less than 10% and only one model (Fox etal 2002) has a change
of more than 50% (see Table 4.7). This is because, although the systolic [Ca2+]i is greatly
increased for models with instantaneous or none CaTRPN, its increase is localized to a
relatively narrow spike with an area that is negligible comparing with that of the rest of the
transient.
Models with dynamic buffers show significant Postextrasystolic Potentiation in [Ca2+]i
Postextrasystolic potentiation exists in intracellular Ca2+ transients, where giving a fixed
and long enough PESI, as the ESI increases, the amplitudes of the [Ca2+]i of the ES beats
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Figure 4.6: [Ca2+]i shape changes for models with instantaneous buffers. Figures show
the Ohara etal 2008 model for: (a) [Ca2+]i (grey lines) and d[Ca2+]i/dt (black lines),
before (solid lines) and after (dash lines) the implementation of NL96; (b) zoom in of
d[Ca2+]i/dt; (c) the instantaneous buffer factor β before (solid line) and after (dash line)
the implementation of NL96; (d) intracellular Ca2+ current before (solid line) and after
(dash line) the implantation of NL96.
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Figure 4.7: Postextrasystolic potentiation in [Ca2+]i transient for three models of Type
One and Two: (a)(b) Matsuoka etal 2003 without/with contraction; (c)(d) Iribe etal 2006
without/with contraction (NL96); (e)(f) Shannon etal 2004 without/with contraction. The
first three beats are priming beats; from beat a to beat b are ES beats with different ESIs;
from a’ to b’ are PES beats with a fixed PESI (fully restituted PESI, defined in Step Three
in Section 4.2.5); a and b are corresponding ES and PES beats; so are a’ and b’. Note that
each pair of figures (without/with contraction) has the same axis range.
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Figure 4.8: Postextrasystolic potentiation in [Ca2+]i transient for three models of
Type Three, Four and Five: (a)(b) Mahajan etal 2008 without/with contraction; (c)(d)
Ohara etal 2006 without/with contraction; (e)(f) TenTusscher etal 2006 without/with con-
traction. As in the previous figure, the first three beats are priming beats; from beat a to
beat b are ES beats with different ESIs; from a’ to b’ are PES beats with a fixed PESI. And
each pair of figures (without/with contraction) has the same axis range.
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will increase while the PES beats will show the opposite trend. Representative examples
of the differences in postextrasystolic potentiation before and after the implementation of
NL96 contraction of Type One and Two (Type Three, Four, and Five) models are shown in
Figure 4.7 (Figure 4.8). Figures for all models are in Section B.2 in Appendix B. ES beats
with different ESIs are labeled from a to b; PES beats with a fixed PESI are labeled from
a’ to b’ (see Step Three in Section 4.2.5); a and b (a’ and b’) correspond to ES and PES
paired beats for the shortest (longest) ESI.
From Figure 4.7, Figure 4.8 and Section B.2 in Appendix B we can see that models with
dynamic CaTRPN show a significant postextrasystolic potentiation in the Ca2+ transients.
As ESI increases, the amplitudes of the ES beats increase while the corresponding PES
beats decrease. In addition, there’s no notable difference in Ca2+ transient before and after
the implementation of NL96 contraction (see Figure 4.7 and Section B.2 in Appendix B).
On the other hand, models with instantaneous or none CaTRPN do not show a signifi-
cant postextrasystolic potentiation in the Ca2+ transients. Among the eight models, only
one model (Livshitz etal 2007, see Section B.2 in Appendix B) shows notable amplitude
change in both ES beats and PES beats. Three models (Hund etal 2004, Faber etal 2000
and Ohara etal 2011, see Figure 4.8 and Section B.2 in Appendix B) show increase in ES
beats but no noticeable decrease in PES beats. Four models (Priebe etal 1998, Fox etal 2002,
TenTusscher etal 2006 and Fink etal 2008, see Figure 4.8 and Section B.2 in Appendix B)
show neither considerable increase in ES beats nor decrease in PES beats. Note that these
types of models, as discussed before, show a change in the shape of [Ca2+]i when contrac-
tion is included. However it does not change the postextrasystolic potentiation behavior
much, namely, if the original model has a clear PESP trend, after the implementation, the
new model will still maintain that behavior and vice versa.
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4.3.2 Contraction Results
To investigate how well our EP models with updated contraction can represent postex-
trasystolic dynamics, we calculated the four characteristic curves, for all fourteen models
with the NL96 contraction and compared them with the experimental data from Yue et
al. [105]. Models that can reproduce Yue et al. experiments are considered more physio-
logically correct.
Postextrasystolic Mechanical Restitution Curve (MRCpes)
Representative examples ofMRCpes(dF/dtmax(PES)/dF/dtmax(SS)) for six models are
shown in Figure 4.9. For all the models, MRCpes are given in Section B.3 in Appendix B.
For all modelsMRCpes is well described (r2 > 0.99; averaged over all ESI values) by a
monotonically increasing curve with respect to PESI (Eq. (4.8)) as shown in Table 4.8, after
the elimination of some data points (see the example of Mahajan eral 2008 below). How-
ever not all models were consistent with the experimental findings of Yue et al. [105] whose
C0 = 0. Among the six models with dynamic CaTRPN (Type One, Two, Three), four sat-
isfy this condition, while among the eight models with instantaneous or none CaTRPN
(Type Four and Five), only one satisfies C0 = 0 (see Table 4.8). Here we provide a brief
explanation why C0 does not go to zero for some models in our simulations. We use
Mahajan etal 2008 with NL96 as an example to demonstrate. In Figure 4.10(a)(b)(c) we
plotted the Action Potential (AP), Ca2+ transient and normalized dF/dt transient of Ma-
hajan etal 2008 with NL96 for ESI=500ms. The first beat is the steady priming beat, the
second beat is the ES beat with ESI=500ms and from a’ to d’ are PES beats with PESI from
200 to 650ms. We can observe that the dF/dtmax increases with PESI from beat c’ to d’ but
there is no well-defined trend before c’. Beat a’ and b’ are not clearly separated from the
ES beat and a’ is even almost fused into the ES beat. However, even though beat a’ is very
close to the ES beat, dF/dtmax still does not go to zero. We plotted normalized dF/dtmax
(normalize to steady priming beat) for ESI=500ms and PESI ranges from 200ms to 1200ms
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Figure 4.9: Representative postextrasystolic mechanical restitution curves (MRCpes) for
six models after implementation of the NL96 contraction: (a) Matsuoka etal 2003; (b)
Iribe etal 2006; (c) Shannon etal 2004; (d) Mahajan etal 2008; (e) Ohara etal 2011; (f)
TenTusscher etal 2006.
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Figure 4.10: Details for cases where C0 does not go to zero. We use as example the
Mahajan etal 2008 for ESI=500ms: (a) the action potential (AP), (b) Ca2+ transient; (c)
normalized dF/dt transient (d) normalized dF/dtmax of the PES beats. In (a) (b) and (c), the
first beat is the priming beat; the second beat is the ES beat with ESI=500ms; from a’ to d’
are PES beats with PESI ranges from 200ms to 650ms.
in Figure 4.10(d). We can see that dF/dtmax stops decreasing when PESI is below 300ms
and the minimum value is about 0.4. In order to fit this into Eq. (4.8) we exclude data with
PESI lower than 300ms and set C0 = 0.4. That is the reason for Mahajan etal 2008 and
other eight models, that C0 does not go to zero and also an example of how we choose the
shortest ESI and PESI values.
The experimental results of Yue et al. [105] showed that the fully restituted plateau
value ofMRCpes (CRmax,pes) decreased as ESI increased. From Figure 4.9 and Section B.3
in Appendix B we can see that all models with dynamic CaTRPN show unique plateau val-
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ues for different ESIs while models with instantaneous or no CaTRPN converge to the same
plateau values for different ESIs; this property will be further discussed in Section 4.3.2.
The time constant for MRCpes (Tmrc,pes) did not vary much as a function of ESI in the
experiment of Yue et al. [105]. In addition, a leftward shift of the MRCpes was observed
as ESI decreased, presented as an increase of to,pes as ESI increased. The fourteen models
behave differently regarding these two parameters. We will discuss these in detail in the
to,pes and Tmrc,pes subsections.
Postextrasystolic Potentiation Curve (PESPC)
Figure 4.11 shows representative postextrasystolic potentiation curves (PESPCs) for six
models. Figures for all the models can be found in Section B.4 in Appendix B. To pro-
vide a better picture of the amplitude and time constant of the PESPC we simultaneously
plotted the PESPC and the Extrasystolic Mechanical Restitution Curve (MRCes). Note
that for those models with C0 6= 0 in the MRCes, we have shifted the curves upward by
C0 when plotting the PESPC (star *) on the same graph with the MRCes (open circle o)
for comparison. We also use 95% confidence bounds as error bars for each data point on
PESPC, which is the fitting confidence bound for CRmax,pes of each ESI value. Note that
confidence bounds are relatively small compared to the scale of the graph.
A list of all parameters for the curve fitting of Eq. (4.9) are listed in Table 4.8 for
all the models along with the experimental data of Yue et al. [105] to allow comparison
between our simulation results and those from the experiments. The values without any
symbol match the experiment results well. They are either parameters with 95% confidence
bounds overlapping the mean plus/minus standard deviation (mean±SD) range from Yue
et al. or they have r2 values that are higher than 0.99. The double and the triple star (**
and ***) means the 95% confidence bound overlaps Yue et al. datas mean±2SD and the
mean±3SD respectively. The X mark means the confidence bound overlaps the mean±SD
but the confidence bound is too large (more than 50% of the center value) so that we did not
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Figure 4.11: Representative postextrasystolic potentiation curve (PESPC, circles o) and
extrasystolic mechanical restitution curve (MRCes, stars *) for six models: (a) Mat-
suoka etal 2003; (b) Iribe etal 2006; (c) Shannon etal 2004; (d) Mahajan etal 2008; (e)
Ohara etal 2011; (f) TenTusscher etal 2006. 95% confidence bounds of CRmax,pes are
plotted as error bars on PESPC but since the confidence bounds are small compared to
the entire scale, they are not clearly observed in the figures.
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consider this as a real overlapping. The double X mark (XX) means the confidence bound
does not overlap the mean±nSD from Yue experiment with n ≤ 3. The single-dagger (†)
means the r2 is less than 0.99 but more than 0.9 and the double-dagger (‡) means it’s less
than 0.9.
The experiments of Yue et al. showed that PESPC decreased monoexponentially to
a plateau level as ESI increases (Eq. (4.9) and Figure 4.3(b)), meaning that when PESI is
fixed and long enough, the maximum force changing rates of the PES beats will decrease as
ESI increases. Models with dynamic CaTRPN (Type One, Two and Three) have PESPCs
well described by Eq. (4.9); all six models have r2 values larger than 0.99. On the other
hand, models with instantaneous or no CaTRPN (Type Four and Five) are not well fit by
Eq. (4.9). Four of the eight models have r2 values lower than 0.9 with one of them as low
as 0.0048 (Priebe etal 1998). However, the poor quality of the fitting is not evident on
Figure 4.11 or Section B.4 in Appendix B)) because the amplitude of the PESPC is much
smaller than the scale of the figure.
The plateau levels (B) of CRmax,pes for the fourteen contraction models are more sim-
ilar to the experiment results compared to the other parameters. In Yue et al. [105], the
mean value (±SD) for B is 1.05±0.13. In our simulations, two out of the six models
with dynamic CaTRPN (Type One, Two and Three) have 95% confidence bounds over-
lap the mean±SD range of Yue et al. [105] and four have confidence bounds overlap the
mean±2SD range. On the other hand, only two out of eight models with instantaneous or
no CaTRPN (Type Four and Five) have 95% confidence bounds overlap the mean±2SD
range.
Parameter A has the least matching degree with Yue et al. [105] where the mean value
(± SD) is 1.68±0.32. Only one out of the six models with dynamic CaTRPN (Type One,
Two and Three) have 95% confidence bounds overlap the mean±2SD range from Yue pa-
per and none of the models with instantaneous or none CaTRPN have confidence bounds
overlapping this range (see Table 4.8). The values of A from our contraction models are
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significantly smaller than Yue paper. This feature is well depicted in Figure 4.11 and Sec-
tion B.4 in Appendix B in which the PESPCs of the models with instantaneous buffers
have slopes of approximate zero while in the Yue et al. paper there exhibited a pronounced
monoexponentially decay (Figure 4.3). The insufficient change in fully-restituted contrac-
tile strength of postextrosystoles with respect to varied ESIs indicates a clear limitation of
these models as we will further comment in the discussions section.
to,pes is obtained by calculating where the Extrasystolic Mechanical Restitution Curve
(MRCes) intercepts the line
dF/dtmax,es
dF/dtmax,ss
= C0 . The mean value (±SD) in the Yue et
al. [105] is 284±32ms. Four out of six models with dynamic CaTRPN (Type One, Two
and Three) and five out of eight models with instantaneous buffers (Type Four and Five)
are in the mean±2SD range. For this parameter, it seems that the dynamic buffers do not
show much advantage over instantaneous buffers. However, in the Yue et al. paper, this
interception is where MRCes intercepts with the line
dF/dtmax,es
dF/dtmax,ss
= 0, so are four out of
the six models with dynamic CaTRPN. But for most models with instantaneous buffers,
this parameter is where MRCes intercepts with the line
dF/dtmax,es
dF/dtmax,ss
= C0 with C0 6= 0.
Therefore models with dynamic buffers still match this parameter better to the experimental
data of Yue et al. [105].
The mean value (±SD) of the time constant for PESPC (Tpespc) is 176±18ms in Yue
et al. [105]. Only two out of the six models with dynamic CaTRPN (Type One, Two, Three)
and none of the models with instantaneous or none buffers (Type Four and Five) have 95%
confidence bounds that overlap the experimental mean±2SD range. Ten other models have
time constants much larger (50% more) than Yue et al. [105]. This parameter is also the
worst fit for models with instantaneous or no CaTRPN; five out of eight models have 95%
confidence bounds larger than 50% of the center values, indicating a poor fit.
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Minimum-value Axis Intercept Curve (to,pes)
Figure 4.12 shows Minimum-value Axis Intercept Curves for six models. Open circles (o)
are for different ESI values. Error bars are 95% confidence bounds. Figures for all models
are provided in Section B.4 in Appendix B and the summarized data is in Table 4.9.
In the Yue et al. paper [105], to,pes increased as ESI increased. They explained this
trend by suggesting that the refractory period is an increasing function of ESI. Five out of
six models with dynamic CaTRPN (Type One, Two and Three) show the same trend as Yue
et al. paper with to,pes increasing exponentially with ESI; only the Iribe etal 2006 model
shows a non-monotonic behavior. Three out of eight models with instantaneous buffers
(Type Four and Five) show the same trend as Yue et al. (Hund etal 2004, Livshitz etal 2007
and Ohara etal 2011) while three models show a monotonically decreasing trend
(Faber etal 2000, TenTusscher etal 2006 and Fink etal 2008) and two (Priebe etal 1998
and Fox etal 2002) do not have monotonic behaviors. The range of to,pes of the models
match Yue et al. paper well as thirteen out of fourteen models fall within the experimental
range.
Time Constant Curve (Tmrc,pes)
Figure 4.13 shows six Time Constant Curves, i.e. time constants of MRCpes (Tmrc,pes)
vs ESI for 6 models, where the dash line indicates the mean Tmrc,pes from the Yue et al.
paper; the gray area denotes the range of the mean±SD range. Open circles (o) are Tmrc,pes
from curve fitting for different ESI values. Error bars are 95% confidence bounds. Figures
for all the models are in Section B.6 in Appendix B. There were two major results in Yue
et al. [105] regarding Tmrc,pes. First, Tmrc,pes varied little with ESI; the mean (±SD) was
181±41ms and the normalized mean (normalize to Tmrc,es) was 1.01±0.12. In our simula-
tions, all of the models have their normalized time constant values overlap the mean±2SD
range from Yue paper while ten of the models have their Tmrc,es (identical to Tmrc,pes with
ESI=500ms in simulations) overlap the mean±2SD range from Yue paper. Therefore our
56
Figure 4.12: Representative minimum-value axis intercept curve (to,pes) for six models: (a)
Matsuoka etal 2003; (b) Iribe etal 2006; (c) Shannon etal 2004; (d) Mahajan etal 2008;
(e) Ohara etal 2011; (f) TenTusscher etal 2006. 95% confidence bounds of to,pes are plot-
ted as error bars.
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contraction models fit this property with Yue paper quite well. The second major result
from Yue paper is that the time constants of PESPC and MRCpes were close; the mean
difference between the two time constants (±SD) was 13±23ms. Models with dynamic
CaTRPN (Type One, Two and Three) are more consistent with the experiments than instan-
taneous buffers (Type Four and Five) in this respect. Three out of six models with dynamic
buffers have 95% confidence bounds that overlap Yues mean±2SD range while only one
out of eight models with instantaneous buffers overlaps that. Six of them have large 95%
confidence bounds inherited from the large Tpespc bounds, so we marked them by a sym-
bol ℵ, indicating the 95% confidence bounds overlap Yue’s mean±SD but the confidence
bound is so large (more than 3SD) that we do not consider this as a real overlapping.
4.3.3 Underlying mechanism for postextrasystolic potentiation
There is a clear resemblance between the intracellular Ca2+ dynamic and the force dy-
namics. And since the Ca2+ released from SR (Jrel) is the main source for intracellular
Ca2+, we propose that Jrel dynamics, which depends on RyR, Ca2+SR, among others, is the
primary determinant of PESP dynamics.
To verify this hypothesis, we analyzed, for each model, the correlation between the de-
pendence of the potentiation in Ca2+ released from SR (Jrel) and the contractile strength
on pacing intervals. In this study we have shown two sets of curves demonstrating the
potentiation strength: the Postextrasystolic Mechanical Restitution Curve (MRCpes) and
the Postextrasystolic Potentiation Curve (PESPC). The former demonstrates how postex-
trasystolic contractile strength changes with respect to various PESI for a fixed ESI. From
Figure 4.9 and Section B.3 in Appendix B, it can be seen the consistency of the increas-
ing trend of the normalized force changing rate with respect to PESI for all models studied.
However, the PESPC, which shows how postextrasystolic contractile strength changes with
respect to various ESI values for a fixed and long PESI, differs among models: models
with dynamic buffers showed significant variation in contractile strength with respect to
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Figure 4.13: Representative time constant for MRCpes curve (Tmrc,pes) for six models: (a)
Matsuoka etal 2003; (b) Iribe etal 2006; (c) Shannon etal 2004; (d) Mahajan etal 2008;
(e) Ohara etal 2011; (f) TenTusscher etal 2006. Error bars are 95% confidence bounds.
The dash line indicates mean Tmrc,pes for ESI=460ms from Yue et al. The gray area denotes
their standard deviation range.
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Table 4.1: Terminology: definition of variables. Yue et al. 1985 paper measured pressure changing rate. In our simulations we calculate




SSI (PI,PP) Steady state interval (or priming interval/priming period): interval between steady state stimuli. It’s 500ms in our simulations
ESI Extrasystolic interval: interval between extrasystolic and the last steady state stimuli
PESI Postextrasystolic interval: interval between postextrasystolic and extrasystolic stimuli
Measured
quantity
dP/dtmax(SS) Maximum pressure rising rate of steady state beats
dP/dtmax(ES) Maximum pressure rising rate of extrasystolic beats
dP/dtmax(PES) Maximum pressure rising rate of postextrasystolic beats




MRCpes Postextrasystolic mechanical restitution curve: normalized dP/dtmax of postextrasystoles plotted vs PESI
MRCes Extrasystolic mechanical restitution curve: normalized dP/dtmax of extrasystoles plotted vs ESI
PESPC Postextrasystolic potentiation curve: normalized dP/dtmax of fully restituted postextrasystoles (CRmax,pes) plotted vs ESI
Parameters
for MRCpes
CRmax,pes Maximum postextrasystolic contractile response: plateau value for MRCpes
Tmrc,pes Time constant for MRCpes






Table 4.2: General information of 14 electrophysiological models including classification of models (model type, model name, species,
type of intracellular Ca buffers) and model properties (number of variables in the original model, stimulus current amplitude and dura-
tion).
Model Type Model Name Species CaTRPN Buffer Other Ca2+ Buffer No. of Variables Stimulus Current (A/F) Stimulus Duration (ms)
Type
One
Matsuoka etal 2003 guinea pig NL96 none 37 -8 1
Iribie etal 2006 guinea pig RWH99 dynamic 23 -4 2
Type
Two
Shannon etal 2004 rabbit dynamic dynamic 39 -15 4
Grandi etal 2010 human dynamic dynamic 39 -9.5 4
Type
Three
Mahajan etal 2008 rabbit dynamic instantaneous 26 -30 2
Iyer etal 2004 human dynamic instantaneous 67 -25 2
Type
Four
Hund etal 2004 dog instantaneous instantaneous 29 -30 2
Faber etal 2000 guinea pig instantaneous instantaneous 25 -25.5 2
Livshitz etal 2007 guinea pig instantaneous instantaneous 18 -15 2
Ohara etal 2011 human instantaneous instantaneous 41 -80 0.5
Priebe etal 1998 human instantaneous instantaneous 22 -30 2
Type
Five
Fox etal 2002 dog none instantaneous 13 -80 1
TenTusscher etal 2006 human none instantaneous 19 -51 1
Fink etal 2008 human none instantaneous 27 -24 2
Table 4.3: General information of 14 electrophysiological models including parameters of CaTRPN (Kd, Kon, Koff ), approximate time
to reach quiescent states, beat number to reach priming steady states and ESI,PESI ranges.
Model Type Model Name Kd (mM) Kon (mM−1ms−1) Koff (ms−1) Quiescent time Prime beat No ESI(ms) PESI(ms)
Type
One
Matsuoka etal 2003 7.69E-04 3.90E+01 3.00E-02 20min 500 250-1200 100-1200
Iribie etal 2006 function of F 8.00E+01 3.00E-01 10min 500 200-1200 100-1200
Type
Two
Shannon etal 2004 6.00E-04 3.27E+01 1.96E-02 20min 1500 200-1200 100-2000
Grandi etal 2010 6.00E-04 3.27E+01 1.96E-02 20min 500 300-1200 200-1200
Type
Three
Mahajan etal 2008 6.00E-04 3.27E+01 1.96E-02 10min 1500 300-1200 200-1200
Iyer etal 2004 1.00E-03 4.00E+01 4.00E-02 40min 15000 250-1500 200-1500
Type
Four
Hund etal 2004 5.00E-04 3.58E+01 1.79E-02 80min 6000 10500 250-1200 150-1200
Faber etal 2000 5.00E-04 3.58E+01 1.79E-02 20min 1500 200-1500 350-1500
Livshitz etal 2007 5.00E-04 3.58E+01 1.79E-02 20min 1500 200-1200 200-1200
Ohara etal 2011 5.00E-04 3.58E+01 1.79E-02 20min 1000 300-1200 200-1200
Priebe etal 1998 5.00E-04 3.58E+01 1.79E-02 20min 1500 400-2000 400-2000
Type
Five
Fox etal 2002 6.00E-04 3.27E+01 1.96E-02 20min 1500 200-2000 200-2000
TenTusscher etal 2006 1.00E-03 2.53E+01 2.50E-02 20min 1500 400-1000 450-1000
Fink etal 2008 1.00E-03 2.53E+01 2.50E-02 40min 1500 350-1200 350-1200
Table 4.4: Quiescent state variables: membrane voltage, intracellular calcium condensation and JSR (or SR) calcium condensation. If
the original model does not have contraction, we run the original model to get quiescent state. If the original model has contraction, we
take out the contraction part and run that to quiescent state.
Model Type Model Name whether original Vm (mV) [Ca2+]i (mM) [Ca2+]JSR (mM) [Ca2+]SR (mM)
Type
One
Matsuoka etal 2003 No -85.9 2.92E-06 4.76E+00 5.50E+00
Iribie etal 2006 No -94.3 5.50E-06 NA 6.82E-03
Type
Two
Shannon etal 2004 Yes -85.4 7.06E-05 NA 4.58E-01
Grandi etal 2010 Yes -81.0 7.08E-05 NA 4.60E-01
Type
Three
Mahajan etal 2008 Yes -86.4 5.31E-05 3.68E-02 7.36E-02
Iyer etal 2004 Yes -91.6 1.40E-05 3.92E-02 7.84E-02
Type
Four
Hund etal 2004 Yes -86.9 8.34E-05 1.27E+00 2.54E+00
Faber etal 2000 Yes -85.3 7.19E-05 1.09E+00 2.18E+00
Livshitz etal 2007 Yes -90.0 8.00E-05 7.20E+00 8.40E+00
Ohara etal 2011 Yes -88.3 5.58E-05 9.82E-01 1.96E+00
Priebe etal 1998 Yes -91.6 9.26E-05 1.58E+00 3.17E+00
Type
Five
Fox etal 2002 Yes -94.3 5.02E-05 NA 1.11E+00
TenTusscher etal 2006 Yes -87.5 2.58E-05 NA 1.87E-01
Fink etal 2008 Yes -86.8 9.05E-05 NA 2.05E+00
Table 4.5: Data for steady priming beat: EP models without contraction.
Model Type Model Name [Ca2+]i diastolic(mM) [Ca2+]i systolic(mM) t1/2(ms) tpeak(ms) Q (mM*ms)
Type
One
Matsuoka etal 2003 1.46E-05 1.50E-03 5.69E+01 2.02E+01 9.80E-02
Iribie etal 2006 1.03E-05 1.50E-03 5.25E+01 2.08E+01 8.40E-02
Type
Two
Shannon etal 2004 1.13E-04 4.80E-04 1.41E+02 4.60E+01 5.90E-02
Grandi etal 2010 1.11E-04 3.82E-04 1.42E+02 5.49E+01 4.49E-02
Type
Three
Mahajan etal 2008 2.04E-04 5.61E-04 1.94E+02 7.90E+01 7.57E-02
Iyer etal 2004 2.33E-04 9.90E-04 2.23E+02 7.80E+01 1.80E-01
Type
Four
Hund etal 2004 1.86E-04 7.37E-04 1.64E+02 4.27E+01 1.02E-01
Faber etal 2000 2.45E-04 2.00E-03 9.75E+01 1.47E+01 2.04E-01
Livshitz etal 2007 1.73E-04 1.40E-03 1.20E+02 2.20E+01 1.61E-01
Ohara etal 2011 1.18E-04 6.52E-04 1.37E+02 4.31E+01 8.74E-02
Priebe etal 1998 4.31E-04 9.73E-04 1.75E+02 1.52E+01 1.10E-01
Type
Five
Fox etal 2002 3.80E-05 1.62E-03 8.22E+01 1.75E+01 1.52E-01
TenTusscher etal 2006 1.51E-04 1.50E-03 1.38E+02 2.93E+01 2.10E-01
Fink etal 2008 1.42E-04 1.50E-03 1.02E+02 3.43E+01 1.72E-01
Table 4.6: Data for steady priming beat: models with NL96 contraction.
Model Type Model Name [Ca2+]i diastolic (mM) [Ca2+]i systolic (mM) t1/2(ms) tpeak(ms) Q (mM*ms)
Type
One
Matsuoka etal 2003 1.49E-05 1.60E-03 5.65E+01 2.01E+01 1.02E-01
Iribie etal 2006 1.04E-05 1.40E-03 5.26E+01 2.06E+01 8.19E-02
Type
Two
Shannon etal 2004 1.12E-04 4.75E-04 1.46E+02 5.80E+01 5.99E-02
Grandi etal 2010 1.14E-04 3.87E-04 1.35E+02 5.48E+01 4.38E-02
Type
Three
Mahajan etal 2008 2.06E-04 5.70E-04 1.89E+02 7.80E+01 7.49E-02
Iyer etal 2004 2.41E-04 1.00E-03 2.16E+02 7.60E+01 1.83E-01
Type
Four
Hund etal 2004 1.95E-04 1.20E-03 7.05E+01 1.18E+01 1.06E-01
Faber etal 2000 2.27E-04 4.80E-03 6.90E+00 3.79E+00 1.80E-01
Livshitz etal 2007 1.86E-04 2.30E-03 2.99E+01 1.60E+01 1.19E-01
Ohara etal 2011 1.29E-04 1.00E-03 5.81E+01 1.66E+01 9.00E-02
Priebe etal 1998 4.23E-04 1.60E-03 1.93E+01 1.01E+01 1.11E-01
Type
Five
Fox etal 2002 1.16E-04 2.79E-04 1.86E+02 1.38E+01 3.35E-02
TenTusscher etal 2006 1.59E-04 2.00E-03 7.47E+01 2.59E+01 2.15E-01
Fink etal 2008 1.49E-04 2.00E-03 5.99E+01 3.14E+01 1.75E-01
Table 4.7: Data for steady priming beat: relative differences between EP models and models with NL96 contractions. † inidcates the
relative difference is between 10% and 50%. ‡ indicates the relative difference is more than 50%
Model Type Model Name ∆ [Ca2+]i diastolic ∆[Ca2+]i systolic ∆t1/2 ∆tpeak ∆Q
Type
One
Matsuoka etal 2003 1.80E-02 6.67E-02 -7.33E-03 -7.52E-03 3.78E-02
Iribie etal 2006 1.06E-02 -6.67E-02 1.54E-03 -9.41E-03 -2.55E-02
Type
Two
Shannon etal 2004 -5.31E-03 -1.02E-02 3.55E-02 2.61E-01‡ 1.53E-02
Grandi etal 2010 2.23E-02 1.23E-02 -4.68E-02 -2.31E-03 -2.45E-02
Type
Three
Mahajan etal 2008 1.03E-02 1.60E-02 -2.58E-02 -1.27E-02 -9.66E-03
Iyer etal 2004 3.31E-02 1.03E-02 -3.15E-02 -2.56E-02 1.72E-02
Type
Four
Hund etal 2004 4.82E-02 6.28E-01‡ -5.71E-01‡ -7.25E-01‡ 3.53E-02
Faber etal 2000 -7.55E-02 1.60E+00‡ -9.29E-01‡ -7.43E-01‡ -1.21E-01†
Livshitz etal 2007 7.47E-02 6.43E-01‡ -7.51E-01‡ -2.73E-01† -2.61E-01†
Ohara etal 2011 9.24E-02 5.34E-01‡ -5.75E-01‡ -6.15E-01‡ 2.97E-02
Priebe etal 1998 -1.69E-02 6.44E-01‡ -8.90E-01‡ -3.36E-01† 1.46E-02
Type
Five
Fox etal 2002 2.05E+00‡ -8.28E-01‡ 1.26E+00‡ -2.12E-01† -7.79E-01‡
TenTusscher etal 2006 5.20E-02 3.33E-01† -4.59E-01† -1.15E-01† 2.43E-02
Fink etal 2008 4.86E-02 3.33E-01† -4.11E-01† -8.53E-02 2.10E-02
Table 4.8: Contraction parameters: MRCpes and PESPC. ** indicates the models 95% confidence bound overlaps the mean±2SD
value in Yue et al 1985 experiment. *** indicates the models 95% confidence bound overlaps the mean±3SD value in Yue et al 1985
experiment. XX indicates the models 95% confidence bound does not overlap the mean±nSD value in Yue et al 1985 experiment with
n3. X indicates the models 95% confidence bound overlaps the mean±SD value in Yue et al 1985 but the bound is more than 50% of
the center value. † indicates 0.9 r2 ≤ 0.99. ‡ indicates r2 < 0.9.
Model Type Model Name
MRCpes PESPC
Mean r square C0 B A to,es(ms) Tpespc(ms) r square
Experiment Yue et al 1985 NA 0 1.05±0.13 1.68±0.32 284±32 176±18 NA
Type
One
Matsuoka etal 2003 0.9967 0 1.13±0.05 0.34±0.04 XX 260±6 704±156 XX 0.9944
Iribie etal 2006 0.9953 0 0.90±0.01 ** 1.01±0.09 ** 119±6 XX 184±13 0.9969
Type
Two
Shannon etal 2004 0.9988 0 1.22±0.01 ** 0.83±0.02 *** 219±6 ** 263±9 XX 0.9996
Grandi etal 2010 0.9991 0 1.47±0.01 XX 0.65±0.02 XX 297±4 221±13 ** 0.9983
Type
Three
Mahajan etal 2008 0.9987 0.4 XX 1.00±0.03 0.47±0.03 XX 344±6 ** 346±49 XX 0.9938
Iyer etal 2004 0.9987 0.4 XX 1.49±0.05 XX 0.48±0.05 XX 366±3 *** 608±96 XX 0.9933
Type
Four
Hund etal 2004 0.9991 0 1.47±0.01 XX 0.02±0.01 XX 233±4 ** 471±320 X 0.9043 †
Faber etal 2000 0.9986 0.7 XX 0.74±0.01 *** -0.01±0.01 XX 334±6 ** 323±46 XX 0.9865 †
Livshitz etal 2007 0.9998 0.5 XX 0.80±0.01 ** 0.04±0.01 XX 312±1 413±100 XX 0.9814 †
Ohara etal 2011 0.9988 0.2 XX 1.33±0.01 *** 0.02±0.01 XX 326±3 ** 322±196 X 0.8848 ‡
Priebe etal 1998 0.9992 1.1 XX 0.77±0.01 *** -0.00±0.01 XX 566±4 XX 232±7809 X 0.0048 ‡
Type
Five
Fox etal 2002 0.9991 0.5 XX 1.32±0.01 ** 0.01±0.01 XX 321±4 ** 328±94 XX 0.9156 †
TenTusscher etal 2006 0.9971 0.9 XX 0.01±32.8 X 0.33±32.8 X 423±9 XX 1.04e4±1e6X 0.4278 ‡
Fink etal 2008 0.9977 0.9 XX 0.31±0.01 XX 0.01±0.01 XX 392±6 XX 190±121 X 0.8208 ‡
Table 4.9: Contraction parameters: to,pes and Tmrc,pes. ** indicates the models 95% confidence bound overlaps the mean±2SD value
in Yue et al 1985 experiment. *** indicates the models 95% confidence bound overlaps the mean±3SD value in Yue et al 1985
experiment. XX indicates the models 95% confidence bound does not overlap the mean±nSD value in Yue et al 1985 experiment with
n3. X indicatese the models 95% confidence bound overlaps the mean±SD value in Yue et al 1985 but the bound is more than 50% of
the center value. indicates the models 95% confidence bound overlaps the mean±SD value in Yue et al 1985 but the bound is more than
3SD. • indicates the plus/minus is the standard deviation. The other plus/minus are 95% confidence range.
Model Type Model Name
to,pes Tmrc,pes
Trend w.r.t. ESI Range(ms) Tmrc,es(ms) Mean±SD • Tpespc-Tmrc,es(ms)
Experiment Yue et al. 1985 Monotonic increase 180-420 181±41 1.01±0.12 13±23
Type
One
Matsuoka etal 2003 Monotonic increase 167-335 187±13 1.15±0.12 517±156 XX
Iribie etal 2006 Not monotonic XX 78-120 XX 110±9 ** 1.52±0.71 74±13 ***
Type
Two
Shannon etal 2004 Monotonic increase 163-252 262±16 ** 0.98±0.17 1±16
Grandi etal 2010 Monotonic increase 245-350 234±10 ** 1.01±0.11 -13±13
Type
Three
Mahajan etal 2008 Monotonic increase 221-454 238±14 ** 1.04±0.08 108±49 **
Iyer etal 2004 Monotonic increase 305-498 333±10 XX 1.04±0.04 275±96 XX
Type
Four
Hund etal 2004 Monotonic increase 126-242 234±9 ** 1.00±0.02 237±320 ℵ
Faber etal 2000 Monotonic decrease XX 297-342 300±13 *** 1.02±0.04 23±46
Livshitz etal 2007 Monotonic increase 232-333 203±3 1.02±0.06 210±100 XX
Ohara etal 2011 Monotonic increase 226-380 193±8 1.04±0.02 129±196 ℵ
Priebe etal 1998 Not monotonic XX 377-624 438±14 XX 1.04±0.03 -206±7809 ℵ
Type
Five
Fox etal 2002 Not monotonic XX 244-380 370±8 XX 1.00±0.02 -4294 ℵ
TenTusscher etal 2006 Monotonic decrease XX 402-437 209±25 1.04±0.04 1.02e4±1e6 ℵ
Fink etal 2008 Monotonic decrease XX 341-420 256±18 ** 1.0±0.03 -66±121 ℵ
ESI while models with instantaneous buffers showed little variation (Figure 4.11 and Sec-
tion B.4 in Appendix B). The amplitude (parameter A) in PESPC captures this difference.
Since we are interested in what causes the difference in models, we studied the correlation
between the Ca2+ released from SR (Jrel) and the contractile strength of the postextrasys-
toles with various ESIs and fixed a PESI. We designed an analogous parameter AJ for the
Jrel amplitude. Similar to our dF/dtmax fit, for a fixed ESI, we first fitted the normalized
Jrel max (to the prime beats) of the postextrasystolic beats to a mono-exponentially increas-
ing curve with respect to PESI (analogous toMRCpes). For most models, Jrel max was well
described by a mono-exponential increasing curve, similar to the contractile strength. Then
we fitted the plateau values of these curves to a mono-exponentially decreasing curve with
respect to ESI (analogous to PESPC); we define the amplitude of this curve as AJ . Models
with larger AJ suggest that their fully-restituted Jrel max vary with respect to ESI. There-
fore the correlation between A and AJ can be used as a gauge for the correlation between
the dependence of Jrel and the contractile strength on pacing intervals. We performed a
linear regression for AJ and A for thirteen (out of the fourteen) electromechanical models
as shown in Fig 11. We found a strong positive correlation (r2=0.848) between the two
parameters. In addition, data from models with instantaneous buffers clustered around the
origin while data from models with dynamic buffers were distributed along the regression
curve. This means for models with instantaneous buffers, the insufficient variation in
the fully-restituted postextrasystolic contractile strength responding to various ESI is
a direct result of the Jrel dynamics. Note that the model excluded from the linear regres-
sion was TenTusscher etal 2006 (upward triangular mark in Figure 4.14) because the curve
fitting for parameter A in this model is not reliable due to its large 95% confidence bound
(see Table 4.8).
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Figure 4.14: Correlation between the potentiation in Jrel and contractile strength: the Pos-
textrasystolic Potentiation Curves (PESPC) amplitude of contractile strength (A) vs that of
calcium released from SR (AJ ).
4.4 Discussion
4.4.1 Verifying the choice of contraction model
To assess the robustness of the contraction model we use, we conducted more careful veri-
fications in Appendix C and Appendix D.
In Appendix C, we compared NL96 with two other contraction models: i) NL96 and
RWH99 implemented in Iribe etal 2006; ii) dynamic (original) NL96 and instantaneous
NL96 implemented in Ohara etal 2011. In the first set of comparison, we conclude that un-
der the isometric condition there are no significant differences between NL96 and RWH99
under the scope of this study in the sense that each one matches different parameters with
experiments better than the other. In the second set of comparison we find that although
including NL96 in models with instantaneous CaTRPN distort their Ca2+ shape, the poor
contraction behaviors of these models are not directly related to that. Two simulation re-
sults support this conclusion. First, their original models do not show clear postextrasys-
tolic potentiation behavior in Ca2+ (see Figure 4.8), which is directly related to the lack of
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variation in contractile strength and second, Ca2+ shape is retained after the implementa-
tion of the instantaneous NL96 yet the contraction behavior of Ohara etal 2011 is still not
optimal.
Finally in Appendix D, we conducted verifications of physiological parameters such
as different priming period, low temperature and cooperativity of the contraction model.
By comparing simulation results before and after modification of these physiological pa-
rameters, we showed that the choice of parameters did not change quantitatively the PESP
behavior.
4.4.2 Conclusion and limitation
Simulations of electrical therapies for HF (e.g., CRT and CCM) require models that ac-
curately reproduce the excitation-contraction coupling that occurs in the cardiac myocyte.
While action potential duration restitution curves tend to be used to help validate EP mod-
els, there has been no systematic method to validate cellular contraction models. We sug-
gest that the PESP protocol can be used in the validation process of mathematical models
of cellular electromechanics and we present a methodology to include mechanics into cel-
lular EP models of various types and compare results among the models with and without
contraction. The results from this study suggest four reasons why electrophysiology mod-
els with dynamic CaTRPN are much better candidates to implement contraction than EP
models with instantaneous or none CaTRPN.
First, the complexity in implementation is greatly reduced since the original models are
already equipped with dynamic equations for CaTRPN. Type Two and Type three models
only take one step in the implementation flowchart while Type Four and Type Five require
one or two more steps to add in instantaneous CaTRPN and change that into a dynamic
form (see Appendix A).
Second, the inclusion of contraction does not disturb properties in the original mod-
els. The Ca2+ shape shows minimum change for models with dynamic buffers while it
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is largely distorted for models with instantaneous or none CaTRPN (Figure 4.5 and Sec-
tion B.1 in Appendix B). This is closely related to the first benefit as it requires adding extra
terms into Type Four and Type Five models to incorporate contraction and therefore Ca2+
shapes are more likely to be unphysiologically deformed.
Third, models with dynamic CaTRPN show clear postextrasystolic potentiation inCa2+
with or without contraction implemented (see Figure 4.7, Figure 4.8 and Section B.2 in
Appendix B). Therefore these models show desired variation in contractile strength of ex-
trasystoles and postextrasystoles because of the close relationship between Ca2+ and con-
traction.
Fourth, contraction properties of models with dynamic CaTRPN fit experimental re-
sults better (see Figure 4.9 comapring with Figur 4.3(a), Figure 4.11 comparing with Fig-
ure 4.3(b), Figure 4.12, and Figure 4.13). This has been shown in the four characteristic
curves (Postextrasystolic Mechanical Restitution Curve (MRCpes); Postextrasystolic Po-
tentiation Curve (PESPC); Minimum-value Axis Intercept Curve (to,pes) and Time Constant
Curve (Tmrc,pes)) and their various parameters.
To unveil the mechanism why model with dynamic buffers reproduce PESP better than
models with instantaneous buffers, we studied the correlation between contraction and cal-
cium release from SR. We found a strong positive correlation (r2=0.848). This means for
models with instantaneous buffers, the insufficient variation in contractile strength respond-
ing to various pacing cycle length is a direct result of theCa2+ dynamics. The interpretation
for this result is twofold. First, Ca2+ release from SR is the main source for intracellular
Ca2+, therefore Jrel can be the direct reason of contraction behaviors. Second, time con-
stants play a crucial role in cell contraction. The time constants of binding with troponin
C in Eq. (4.3) in models with dynamic buffers are in the order of 10ms, which is the same
order of the time scales of the upstroke of Ca2+, CaTRPN and tension development. The
RyR release kinetics is highly timing sensitive and strongly coupled to the binding pro-
cess. Therefore models with dynamic buffers, which can describe the timing of interaction
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among different cell compartments more accurately, reproduce correct contraction behav-
iors. This has biological significance since most electrophysiological models incorporate
instantaneous buffering due to their simplicity and lower computational cost.
Limitation
Yue’s experiments are based on dog ventricles in iso-volume conditions, but our simula-
tions are on isometric single cells. However similar experiment results have been observed
in smaller tissue sizes. Wier et al. [110] measured tension in perfused ferret papillary mus-
cles 0.67±0.05mm in external diameter and reported similar monoexponential curves as
Yue et al.. We do consider the size to be a potential limitation of our work. Qualitatively
we get similar characteristic curves in our simulations as in the experiment but quantita-
tively none of our models show as much variation in contraction strength with respect to
changing stimulus rate (see Figure 4.9 and Figure 4.11) as in Yue’s experiment. One pos-
sible reason might be that the coupling and isotropy in tissues reinforce the variation in
contractile strength, which suggests tissue simulations should be one direction for future
work.
Another limitation on using some of the cell models is the coupling of cross species
models and the comparison to experimental data from another species. The argument is
that, first, the parameters in the experiment and simulations that we performed quantita-
tively cross species comparisons on are all normalized to their own priming beats (Fig-
ure 4.9 and Figure 4.11); the normalization should reduce the species sensitive factors.
Second, the quantities that are not normalized are either compared before and after the
contraction implementation within each own individual model (Figure 4.5, Figure 4.7, Fig-
ure 4.8) or compared qualitatively with the experiment (trends with respect to ESI in Fig-
ure 4.12 and Figure 4.13). Nevertheless we admit this is a limitation in our work due to the
lack of experiment data for all species.
In our study, we chose a hybrid approach to implement contraction that we only changed
CaTRPN into a dynamic buffer while kept all the other buffers instantaneous. The reason
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for that is because we want to change the original model as little as possible. Since only
CaTRPN is presented in the contraction model, we think it should be enough to change
only that into a dynamic buffer. We did conduct simulations on O’Hara et al. that we
changed both of the instantaneous intracellular calcium buffers in the model (troponin and
calmodulin) into dynamic buffers using the same strategy described in Section 4.2.3. We
found that the shapes of both voltage and calcium are significantly retorted (not shown).
It is not surprising because the more changes we make, the less the model’s behavior will
resemble the original model. That’s why we think our study is informative and important
for people in the field to realize the importance of models with dynamic buffers in repro-
ducing contraction behaviors since the form of the equations for CaTRPN in those models




5.1 Introduction to this Chapter
Long-QT syndrome (LQTS), characterized by abnormal prolongation of the QT inter-
val [125], is a result of delayed repolarizations in the heart and can increase the risk of
life-threatening arrhythmias, with a mortality rate of 20% within the first year after first de-
tection and up to 50% in the next 10 years for untreated patients [126]. The known dangers
of LQTS have resulted in guidelines by the FDA concerning the design and testing of any
new drug and in the interpretation and analysis of these drugs in clinical trials [127]. In ad-
dition, many currently available medications can be very dangerous to some patients with
heart problems, as they are known to further prolong QT intervals as shown in the com-
pendium maintained by the Sudden Arrhythmia Death Syndromes Foundation (sads.org).
LQTS is usually accompanied by T-wave alternans [128] where the duration of the T wave
can vary from one beat to the next [129]. This long-short alternation in duration and in
some cases amplitude has been shown to arise from a period-doubling bifurcation [20, 21]
originating at the cellular level [22]. In space, alternans can lead to complex spatiotempo-
ral patterns along the epicardium and endocardium [23] and eventually to conduction block
and fibrillation [24, 25].
Alternans was observed in cardiac tissue as early as 1872 [130], and some of the ear-
liest mathematical models of cardiac action potentials were able to produce such phenom-
ena [69, 68]. However, later generations of models often failed to produce alternans [71,
112, 70, 73], with more detailed species-specific models for rabbit [74, 114], dog [131] and
human [78, 119, 75] ventricular action potentials among them. In time, other models have
been specifically designed to account for alternans [117, 115, 77, 132].
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Recently the FDA’s sponsored Cardiac Safety Research Consortium [133] proposed a
new initiative, the Comprehensive in-Vitro Pro-arrhythmia Assay (CiPA), which specifies
the use of mathematical models of cardiac action potentials in the aid of pro-arrhythmic
drug risk assessments. Many recently developed ionic models are complex single-cell
models with a large number of variables. There exists a large variability in dynamics be-
tween them as well as failures to reproduce key physiological features when they are tested
in tissue (alternans, reentrant wave dynamics, dominant frequencies, etc.). The known
differences between many cell and tissue models make it imperative to validate and
verify models with experiments.
In this chapter, we compared the voltage and calcium alternans in Sato et al. [132]
model with dual optical mapping recordings for [Ca2+]i and Vm during discordant alternans
in Langendorff-perfused rabbit hearts to verify if the model can produce correct dynamics
of the development of alternans.
5.2 Experimental setup
The heart preparations and optical mapping setups were described in Chapter 2. New
Zealand white rabbits (2-3 kg, n=8) were used. A total of six high-power LEDs were used
for excitation, three were for voltage imaging and the other three were used for calcium
imaging.
External bipolar stimuli (3-5 ms, strength is twice of the diastolic threshold) were ap-
plied from the apex or the base using a downsweep pacing protocol with the pacing cycle
length (PCL) starting from 400ms. For each PCL, 150 to 200 stimuli were delivered to
allow the system to reach steady state. The PCL was gradually shortened with decreasing
steps once alternans started to appear until the occurrence of VF or wave block at any point
along the wavefront propagation, usually between 150ms to 130ms.
Alternans in voltage was quantified by measuring the action potential duration (APD)
and the alternans in calcium by measuring the the calcium transient duration (CaD). When
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calculating the APD and CaD, the voltage and calcium signals were first normalized be-
tween 0 and 1 for each pixel. Then the APD was calculated using a threshold of 0.5, and
the CaD was calculated using a threshold of 0.4.
5.3 Simulation setup
The Sato et al. model (Sato et al., 2013) for rabbit ventricular cells in space was used
under conditions similar to those of the rabbit experiments. For the details of the ionic
current, please see reference [132]. Briefly, each cardiac cell of a one-dimensional cable of
tissue is modeled by 75 sarcomeres connected through the diffusion of cytosolic calcium
(Cai) and network sarcoplasmic reticulum (NSR) calcium. The diffusion strengths are
8× 10−9cm2/ms and 4× 10−10cm2/ms respectively. Voltage in the 75 sarcomeres within
one cell is considered to be the same due to the fast diffusion inside a cell. Each sarcomere
consists of four compartments: cytosol, submembrane, NSR and junctional SR (JSR). See
Figure 5.1. The calcium fluctuation is model by the Langevin equation with a noise term
depending on the number of SERCA pumps.
One-dimensional tissue is modeled by the cable equation 3.2, in which the ionic current
is













Index i indicates the ith cell in the 1D cable and the index j indicates the jth sarcomere in
one cell. M is the total number of sarcomeres in one cell (i.e. 75 in our simulations). The
cable equation is integrated using an operator splitting approach with ∆x = 0.015cm and
∆t = 0.1ms. The diffusion of calcium between cells is considered negligible. The cable
length is 3cm. Neumann boundary condition is used.
In the previous chapter, we have emphasized on the importance of including contraction
in electrophysiology models. We did not include contraction in Sato et al. model because
in our experiments, we used blebbistatin to suppress the contraction for better visualization
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Figure 5.1: Schematic illustration of the multi-scale computational model. Figure from
Sato et al. [132]
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of the electrical signals.
Three different pacing protocols were used for the 1D simulations, with each using a
stimulus current applied to the five leftmost cells for a duration of 2ms. In the first pacing
protocol, we started with PCL = 600ms until steady state was reached, then decreased the
PCL to 300ms and paced until steady state was reached. In the second pacing protocol,
we initially assigned to the whole cable the steady state variables for the leftmost cell for
PCL = 600ms, then we gradually decreased the PCL to 300, 295, 290, 285, 280, 270, and
260ms. For PCLs longer than 300ms, we used the third pacing protocol, in which we used
the steady state of PCL = 300ms from the second protocol as the initial condition. When
calculating APD, -80mV (about 80% repolarization) was used as the threshold. When
calculating CaD, the threshold was set to be between 10% and 20% of the repolarization,
adjusted among different pacing cycle lengths to make sure both even and odd beats can be
captured.
5.4 [Ca2+]i alternans develops at longer PCLs than APD alternans in experiments
The spatiotemporal dynamics of voltage and calcium in cardiac tissue depends on the pac-
ing period. Figure 5.2A shows snapshots of voltage (upper two rows) and calcium (lower
two rows) in a rabbit ventricle for a series of PCLs from 350 to 140 ms when stimulation
was applied at the base of the heart. Each column shows consecutive even and odd images
during steady state 120 ms after stimulus application; all frames over two successive beats
at steady state are shown in Movie 1 in Appendix G. Figure 5.2B shows the same situation
but when the stimulus was applied to the apex, and Movie 2 shows all frames over two
successive beats at steady state for this case. In all rabbit experiments, Ca alternans clearly
developed at longer PCLs than voltage alternans. As the tissue was paced more rapidly, in-
homogeneity emerged in both voltage and calcium patterns with calcium displaying more
spatial heterogeneity compared to voltage. Figure 5.3 shows the voltage and calcium sig-
nals, respectively, over time for one pixel indicated by a marker in Figure 5.2 for all PCLs.
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Figure 5.2: Snapshots of normalized voltage (upper two rows) and intracellular Ca (lower
two rows) 120 ms after stimulus application on consecutive beats for decreasing pacing
cycle lengths (PCL) from 350ms to 146ms (left to right). Rabbit ventricle is shown here
from experiments. The long axis of the heart is about 4cm (see Figure 5.5). Stimulus was
applied at (A) the base and (B) the apex.
80
Figure 5.3: Time traces of normalized voltage (top) and [Ca2+]i (bottom) signals from a
single pixel marked in Figure 5.2 for the same PCLs.
As the PCL decreases, alternans was detected first in calcium amplitude (250±10 ms), then
in calcium duration (220±15ms), and finally in APD (200±15ms). The shortest PCLs can
barely generate an excitation in calcium for the short beats (last two panels in Figure 5.3B),
and alternans is more pronounced in both duration and amplitude for the calcium signal.
5.5 Discordant alternans nodes are more pronounced in [Ca2+]i than in APD
Figure 5.4A shows the spatial dispersion of APD for successive beats at steady state. Sev-
eral important features are worth noticing. At long PCLs (e.g., PCL>250 ms), there is no
difference between even and odd beats (no alternans), but there is an intrinsic smooth spatial
dispersion of APDs in the range of 15ms for each beat. As concordant alternans and then
discordant alternans develop, the gradient of APD increases to around 30ms as the PCL
decreases. The distance between the locations of the longest and shortest APD decreases
during Discordant alternans (DA), similar to what has been observed in canine hearts [23].
During DA, the regions of long-short and short-long APD are separated by a collection of
nodes (nodal lines) where the APD remains constant from beat to beat (shown as white
lines in Figure 5.4), with more nodes forming as the PCL decreases. Figure 5.4B shows
the CaD dispersion in tissue, similar to Figure 5.4A. However, during DA, the nodal lines
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Figure 5.4: (A) Spatial distribution in APD for even (top) and odd (bottom) beats at various
PCLs with stimulation applied to the base. Rabbit ventricle is shown from experiments.
The long axis of the tissue is about 4cm (see Figure 5.5). Numbers next to the maps
indicate the maximum and minimum values used in the color map. Notice there is no
alternans for PCL>275 ms, concordant alternans for PCL between 250 and 225 ms, and
discordant alternans for PCLs below 225 ms. Nodal lines are shown in white. (B) [Ca2+]i
spatial distribution for even (top) and odd (bottom) beats as in A, but transitions between
discordant alternans phases are sharper and nodes are more pronounced. (C-D) Spatial
distributions as in (A-B) but for pacing from the apex.
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are thicker and more pronounced compared to voltage nodal lines. Figure 5.4C-D show
plots similar to Figure 5.4A-B for the same preparation but with the pacing site located at
the apex instead of the base. The progression from no alternans to concordant alternans
(CA) and then to DA occurs at the same PCLs, but the spatial patterns are different. This
difference of patterns depending on pacing site was observed in all 8 rabbit experiments as
well as in previous studies [23, 134].
Previous numerical studies of alternans [28, 29, 25, 135] have used one-dimensional
cables to quantify the spatial profiles of APDs, including the number of nodes present.
In the same way, Figure 5.5 and Figure 5.6 displays the values of APD and CaD along a
line across the heart’s surface for two successive beats during alternans. As in Figure 5.4,
it can be seen that there is no alternans for PCL > 250 ms, then concordant alternans in
voltage and calcium appears for PCLs between 200 and 180ms. At 170ms, there is CA
in voltage but DA for calcium, and for PCL < 170 ms DA is present for both voltage
and calcium. We calculated in Table 5.1 the steepness (slope) of the APD and CaD nodal
lines for PCL between 160ms and 146ms corresponding to Figure 5.6I-L when the DA
are most pronounced. Data was presented as mean±s.d. (standard deviation), averaged
among the slopes at each node for even and odd beats for each pacing cycle length. It
clearly shows that CaD nodal lines are about one order of magnitude steeper than APD
nodal lines, indicating the diffusive connection among cells differs in voltage and calcium
signals [136, 137], as the insufficient of diffusion in calcium leads to calcium profiles that
are sharper in space compared to voltage.
5.6 Experimental alternans features smoother spatial profiles and slower alternans
amplitude growth than simulated alternans
Simulation results using the Sato et al. model confirm that alternans appear as the PCL is
decreased. However, the PCLs at which they appear are much longer compared to experi-
ments. Figures 5.7 and Figure 5.8 show the voltage and the calcium alternans in a 1D cable
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Figure 5.5: APD contour and APD and [Ca2+]i alternans duration in ms for even and
odd beats measured along a one-dimensional line shown in black for different PCLs as in
Figure 5.4. Data from rabbit ventricle experiment.
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Figure 5.6: APD contour and APD and [Ca2+]i alternans duration in ms for even and
odd beats measured along a one-dimensional line shown in black for different PCLs as in
Figure 5.4 (Continue). Data from rabbit ventricle experiment.
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Figure 5.7: Voltage alternans in a 1D cable (L = 3cm, 200 cells) of the Sato et al. model
for decreasing PCLs: (A) PCL=400 ms, (B) PCL=300 ms (concordant alternans), (C)
PCL=300 ms (discordant alternans), and (D) PCL=260 ms (discordant alternans). Left
column: spatial profile of APD for odd (black) and even (red) beats. The amplitude of
discordant alternans increases as PCL decreases. Right column: voltage over time at two
cells, one near the left end and the other near the right end of the cable.86
Figure 5.8: Calcium alternans in a 1D cable (L = 3cm, 200 cells, each cell consists of 75
sarcomeres). (A) PCL = 400 ms, (B) PCL=300 ms, (C) PCL=300 ms, and (D) PCL=260
ms. Left column: spatial profile of Ca duration for odd (black) and even (red) beats. Right
column: Ca over time at two sarcomeres that are around the CaD nodal point where they
are completely out of phase when discordant alternans is present.87
Table 5.1: Steepness of APD and CaD nodal lines.









12.1±4.8 12.5±3.7 9.94±2.91 20.1±5.6
3 cm in length. Figure 5.7 illustrates APD as a function of length in the left column for
even and odd beats at PCLs of 400, 300, and 260 ms. The right column shows the voltage
signal for the corresponding PCL for two cells, one near the left end and one near the right
end of the cable, so that if the cable exhibits discordant alternans, the voltage signal of the
two cells should be out of phase. Figure 5.8 shows similar plots but for the calcium. The
left column indicates CaD over the cable for even and odd beats for the same PCLs as in
Figure 5.7. The right column of Figure 5.8 displays the calcium signal from two sarcom-
eres for corresponding PCLs, with the two sarcomeres chosen so that if there is discordant
alternans in calcium, the two sarcomeres should be out of phase. Results for other PCLs
(600, 500, 450, 350, 290, 280, and 270 ms) are presented in supplemental Figure E.1 for
APD and Figure E.2 for CaD.
For large PCLs (>400ms), there is no alternans in either voltage or calcium (Supple-
mentary Figure E.1A-C and E.2A-C). When the PCL drops to 400ms, concordant alternans
appears (Figure 5.7A and Figure 5.8A). For PCLs 300ms or below, discordant alternans oc-
curs (Figure 5.7C-D, Figure 5.8C-D and Supplementary Figure E.1E-G and Figure E.2E-
G). In all these simulations, voltage and calcium alternans are ”synchronized”, meaning
if there is no voltage alternans, there is no calcium alternans, and if there is discordant
voltage alternans, there is discordant calcium alternans, with the exception of Figure 5.7B
and Figure 5.8B. In Figure 5.7B and Figure 5.8B, where we used the second pacing pro-
tocol and the PCL is the same as Figure 5.7C, we obtained concordant voltage alternans,
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whereas the calcium alternans is discordant with multiple nodes. By using different initial
conditions, it is possible to obtain completely different dynamics for the same PCL. The
Sato et al. model is very sensitive to initial conditions due to the random fluctuation term in
the SERCA pump, and in this respect, it is similar to experiments, where it has been shown
that small changes in initial conditions can result in very different alternans patterns [23].
In all the simulations presented in this thesis, the random noise was generated using the
same seed.
One major difference between the experiments and the simulations is how sharp the
calcium transition is between different alternans phases. In the experiments, both APD
and CaD have relatively similar smooth transitions between the maximum and minimum
values (Figure 5.4, Figure 5.5 and Figure 5.6), with calcium showing only a slightly faster
transition, whereas in simulations, CaD has a significantly sharper transition than APD
(Figure 5.7 and Figure 5.8). In addition, in experiments, as the PCL is decreased, CaD tran-
sitions from no alternans to concordant alternans and then to discordant alternans with the
alternans amplitude increasing smoothly. In simulations, on the other hand, CaD changes
drastically from no alternans to concordant alternans with an amplitude of 150 ms when
the PCL decreases from 450 to 400 ms.
Figure 5.9 shows a bifurcation diagram for APD (left) and CaD (right) as a function
of PCL calculated at one point from the numerical simulation of the 1D cable (top) and
experimental data (bottom) where the alternans has the largest amplitude. As the PCL is
decreased from 600 to 260 ms in the numerical simulations, the bifurcation appears simul-
taneously for both voltage and intracellular calcium just above a CL of 400 ms (PCLc).
The bifurcation amplitude for voltage grows is conjectured to be at a rate of the square
root away from the bifurcation point (∆APD ∼ (PCL − PCLc)1/2) [19]. The bifurca-
tion amplitude in calcium experiences a sharp discontinuous jump (Figure 5.10 for the
curve fitting). In contrast, the experimental bifurcations occur at much lower PCLs close to
250ms, and the amplitude of the alternans just beyond the bifurcation can be fit better into
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Figure 5.9: Bifurcation plots of APD (left) and CaD (right) as a function of PCL for simu-
lations (top row) and experiments (bottom row).
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a linear function with a smoother growth than in the simulations.
5.7 Discussion
Patients with LQTS have a higher risk of cardiac arrhythmias due to augmentation of the T-
wave and increased spatial dispersion. For many years now, detection of LQTS and T-wave
alternans in ECG has been used as a quantitative tool for predicting dangerous spatial vari-
ations in dispersion, which are dynamically induced at the cellular level and can induce ar-
rhythmias. Since 2005, the FDA has required that new drugs be tested for QT prolongation
and development of T-wave alternans and recently an FDA-sponsored consortium proposed
an initiative to use mathematical action potential models in the aid of drug risk assessment.
If models are indeed to be used to investigate pro-arrhythmic and anti-arrhythmic effects
of drugs, they first need to be validated against experimental data in normal conditions.
The main goal of this chapter is to create an in tissue experimental data set of simultaneous
voltage and calcium optical mapping recordings from Langendorff-perfused rabbit hearts at
high temporal and spatial resolution and in particular during alternans for use in validating
the dynamics from numerical simulations from the most recent model of rabbit ventricular
action potentials [132].
We found that alternans in voltage and calcium develops similarly in both experiments
and simulations as the pacing cycle length is decreased; however, the model developed
alternans much sooner at longer periods close to 420 ms compared to 240±10 ms in exper-
iments. Likewise, the minimum period of stimulation before conduction block developed
earlier at 260 ms in the model versus 140±5 ms in the experiments. Also, it is important
to notice that in experiments, as in the models, the magnitude in variations of the APD
were much smaller than the variations in CaD during alternans. However, the magnitudes
in alternans were about twice as large in the model as in the experiments, with maximum
values of 55 ms for APD and 150 ms for CaD in the model versus 25±4 ms and 65±5 ms
respectively for the experiments.
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Figure 5.10: Bifurcation amplitude of APD (left) and CaD (right) of experiments (top row)
and simulations (bottom row). We can fit the bifurcation amplitude beyond the bifurcation
point in the experiment into a linear function (∆APD or ∆CaD ∼ (PCL − PCLc))
with r2 of 0.9306 and 0.9739 for voltage and calcium respectively. The voltage bifurcation
amplitude in simulation can be fit into a function ∆APD ∼ (PCL−PCLc)1/2 with r2 of
0.9802.
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Figure 5.11: Action potential amplitude bifurcation from data in Figure 5.3A
More crucial differences arise from the way that the alternans develop. In experi-
ments, alternans in voltage develops gradually, appearing to be more consistent with a
border-collision bifurcation [14, 19, 138], where small changes in duration grow slowly
and mostly linearly, whereas in the model alternans grows much faster, as with a pitchfork
bifurcation [14]. Furthermore, the model does not yield action potential amplitude (APA)
alternans as observed in the experiments when the tissue is paced at very short pacing cycle
lengths (see Figure 5.11 from experiment), an important additional pro-arrhythmic mecha-
nism recently described by Chen et al. [139] and Myles et al. [37]. On the other hand, while
intracellular calcium does display amplitude alternans in both experiments and simulations,
in experiments amplitude alternans develops slowly, while in the model a large difference
in amplitude appears as soon as alternans develops and persists with a similar amplitude
for all periods where alternans is present, as shown in Figure 5.10.
In regard to spatial distributions, in our experiments, we do not detect very sharp cal-
cium duration transitions around nodal lines for most pacing cycle lengths; instead, we
observe a smooth phase transition in both voltage and calcium, albeit with calcium appear-
ing sharper, with more defined nodal lines than those in APD (Figure 5.4 and Table 5.1).
This is contrary to simulations where CaD alternans transition can happen within a cell.
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If the coupling between voltage and calcium is strong, calcium and voltage should have
similar dynamics, i.e. the CaD alternans nodal line should follow that of the APD and
vice versa. Therefore, we think the model, as it was published, lacks necessary coupling
between voltage and calcium.
5.7.1 Shortcomings of the model
While the PCL at which the alternans appears is higher in the model than in the experiments
by approximately 180ms, this difference could be fixed with a simple re-scaling of some of
the time constants of the model. Similarly, the difference between the minimum PCL for
propagation (around 260ms for the model compared to 140ms for experiments) could also
be reduced by modifications to the recovery and inactivation time constants of the sodium
gating variables. Previous publication [140] also showed that CaD alternans patterns can be
smoothed by increasing voltage instability (and/or reducing Ca instability). However, there
exist several other key physiological aspects that would require a more in-depth analysis
and validation of the models equations.
(1) Type of bifurcation. The calcium dynamics should result in a border-collision bi-
furcation with slow linear growth.
(2) Development of alternans in calcium duration. In the model, as soon as alternans
develops in calcium, its amplitude is almost at its maximum (Figure 5.8), whereas in the
experiments, there is a very smooth transition in Ca alternans with decreasing cycle length
(Figure 5.3).
(3) Development of alternans in amplitude. In the model, when alternans in the AP
duration develops, at no point does alternans in AP amplitude appear (Figure 5.7). This
is in contrast to experiments, where at very short cycle lengths alternans in amplitude is
readily observed (Figure 5.3). Recent experiments and theory predict that the presence of
amplitude alternans is key in the development of reentrant arrhythmias [139, 37].
(4) CV and nodal lines. In both simulations and experiments, concordant and discordant
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alternans appears in tissues of similar size of about 3 cm. The conduction velocities are
very different between simulations having a maximum velocity at about 47cm/s, versus
experiments at around 100cm/s. Numerically, this means that if the diffusion coefficient
was modified to fit the experimental CV values, it will result in tissues of more than twice
the size needed experimentally to support discordant alternans.
5.7.2 Limitation
A major limitation of this study in this chapter is that we did not perform the simulations in
2D. The complexity of the calcium alternans will only be linearly rescaled when adding an
extra dimension since calcium signal is local due to the low diffusion constant. However,
the alternans patterns in voltage can be more complex and result in more nodes in each
direction.
When comparing the Ca alternans, the resolution in the experiments is on the cell-level.
However, in the simulations, we simulated the Ca signal on the sarcomere level. Proper
averaging method should be used in order to compare the experiments and the simulations.
We did not consider when comparing the simulation results to the experiments is the
error introduced by the optical mapping technique such as the scattering of the fluorescent
photons. In the future, 2D simulations and scattering models should be used.
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CHAPTER 6
SYNCHRONIZATION AS A MECHANISM FOR LOW ENERGY
ANTI-FIBRILLATION PACING (LEAP)
In this Chapter, we performed both in vitro and in silico experiments to investigate the
mechanism behind LEAP. We observed successful termination of both AF and VF using
LEAP in simulations and ex vivo canine hearts and verified that synchronization from vir-
tual electrodes is the key mechanism for LEAP. We further investigated the role of shock
period and timing in the effectiveness of LEAP.
We induced VF using rapid pacing on canine LV (septum removed), then applied the
LEAP protocol and recorded the voltage on the ventricular surface using optical mapping.
Experimental protocols are described in Appendix F.
Computer simulations in this chapter were performed using a bidomain model (Eq. 3.2)
subject to no-flux boundary conditions. Human atrial cell model was used [141]. The in-
sulating plaque that typically forms between myocardial fibers in older hearts [142] were
modeled by randomly removing gap junctions along short lines (average length 625 µm)
oriented along the fiber direction (average spacing 2.5 mm). Spatial resolution was 250
µm. Time resolution was 0.05ms. Atrial simulations included the ACh-activated K+ cur-
rent [143]. Forward Euler was used to solve the reaction-diffusion equation and GMRes
was used to solve the Poisson equation.
6.1 Termination of fibrillation by LEAP with reduced energy
Figure 6.1 shows an example of LEAP terminating VF in a canine LV (Movie 3) using a
shock period of 95ms, 15ms below the dominant period of fibrillation (Figure 6.2). The
figure consists of six rows. The top panel of each row is the optical mapping voltage. The
top left row (indicated by blue) shows the time evolution of VF. The remaining five rows
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(indicated by red) show the effects of the five shocks; the first 2-3 frames of each row show
depolarization, the next 2-3 frames show repolarization. During the five shocks, an increas-
ing area was captured by each additional pulse until all electrical activity was terminated.
Standard defibrillation was performed on the same heart. For both LEAP and standard
one-shock defibrillation, the electric field amplitude was gradually increased until the min-
imum energy to defibrillate was found. This procedure was performed on 7 ventricles (28
episodes). The energy of each LEAP pulse is 0.19±0.14 (mean ± standard deviation) of
one-shock defibrillation (Figure 6.3A). Similar energy reductions were observed in atria
experiments (Movie 4). The energy of each LEAP pulse is 0.12±0.11 of standard de-
fibrillation (Figure 6.3B) in 5 atria (22 episodes). The total energy for LEAP (5 pulses)
is comparable to the standard one-shock defibrillation, however, the energy reduction per
pulse will lower the pain level for patients.
6.2 Synchronization as the key mechanism for arrhythmia termination by LEAP
To further explore the mechanism of LEAP termination arrhythmia, we performed phase
analysis on the voltage data and displayed the dynamics using a modified Kuramoto plot.
Kuramoto plots [144] are phase diagrams used to quantify synchronization of a system of
oscillators, where the phase of all the oscillators is displayed on a unit circle. Figure 6.4
demonstrates how to make modified Kuramoto plots. From the optical mapping recordings,
we can obtain for every pixel the voltage value of the action potential and assign to that pixel
a phase. To define the phase, we first pick a threshold for the action potential. When the
transmembrane voltage rises/drops across the threshold, we define the phase at that moment
of that pixel to be 0/2π and the phase is evenly distributed from 0 to 2π for the time span
in between. Then the phase of each pixel is presented by a dot on the circumference of
a semi-circle. On the semi-circle, phase evenly increases from 0 to 2π from the left edge
to the right edge of the circumference (we used semi-circle so phase 0 and 2π can be
distinct). Then we repeat the previous two steps for all pixels and color the dots on the
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Figure 6.1: Termination of ventricular fibrillation. Each row (indicated by blue and red)
consists of two panels. Top show voltage on canine LV from optical mapping. Bottom show
modified Kuramoto plots corresponding to the voltage panels above them; colors indicate
the percentage of pixels of the entire preparation in that phase at this time. Top left row
(blue): fibrillation preceding LEAP. The rest rows (red): five electric pulses, 95ms apart
(E=1.4V/cm).
Figure 6.2: Dominant frequency of VF (110ms) and LEAP shocks (95ms). The frequency
spectrum was calculated using the fast Fourier Transform function (fft) from MATLAB.
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Figure 6.3: Ratio of energy used by LEAP compared to that used by standard 1-shock
defibrillation. Error bar is standard deviation. (A) 7 ventricles (28 trials). (B) 5 atria (22
trials).
semi-circle (from cyan to magenta) to indicate (from low to high) the number of pixels
in that phase. By using Kuramoto plots, the time evolution of the dynamics of the tissue
can be better visualized. The red line indicates the threshold above which the tissue is
considered excited.
Figure 6.1 shows the Kuramoto plot in the bottom panel of each row, corresponding
to the voltage signal above it. During VF, the Kuramoto plots show that the phase was
evenly distributed (blue row), indicating the de-coherence in the system. As the electric
shocks were applied (E=1.4V/cm), the phases in all pixels were increasingly synchronized
with each additional pulse until all elements were synchronized and the arrhythmia was
terminated (Figure 6.1 red rows). In later shocks (3-5), both repolarization and depolar-
ization were synchronized. The level of synchronization in repolarization was slightly less
than depolarization. When LEAP failed, it was due to a lack of full synchronization, as
shown in Movie 5, which has the same LEAP parameters as Figure 6.1 but a lower shock
strength of 0.9V/cm. The phase plots show that less synchronization was achieved with
each pulse compared with the successful case. Hence, after the last shock, the few regions
not synchronized to the LEAP frequency restarted and perpetuated the arrhythmia.
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Figure 6.4: The modified Kuramoto plot.
To further verify the synchronization mechanism behind LEAP, we performed com-
puter simulations using the Nygren et al. atrial cell model on a 7cm×7cm tissue with a
fibrillating state driven by four spiral waves (Figure 6.5 and Movie 6) having a dominant
period of T0=201ms. Successful LEAP was simulated with four shocks delivered at the
pacing cycle length of 190ms, with all spiral waves terminated after the fourth shock. Sim-
ilarly, unsuccessful LEAP was simulated with a lower cycle length (164ms), which failed
to terminate the arrhythmia even after ten shocks (Movie 7). Phase diagrams in the simu-
lations, as in the experiments, indicate synchronization of the system resulted in successful
termination, while unsuccessful defibrillation was due to a lack of full synchronization.
6.3 Comparing the arrhythmia-termination mechanisms of LEAP and one-shock
defibrillation
To investigate how arrhythmia termination by LEAP differs from that of one-shock defib-
rillation, we calculated the fraction of tissue excited (FTE) as a function of time for both
cases. We define FTE as the percentage of tissue with a voltage above a given threshold
(40% of the amplitude of the AP). Figure 6.6 shows the voltage signal from one pixel and
the FTE, both as a function of time, for successful LEAP (Figure 6.6A, E=1.4V/cm) and
successful one-shock defibrillation (Figure 6.6B, E=4.67V/cm). During VF, the complex
dynamics resulted in FTE oscillations (between 0.2 and 0.7) as different parts of the tis-
sue continuously depolarized/repolarized, preventing FTE from reaching values close to
1.0/0.0. For both successful LEAP and one-shock defibrillation, FTE reached 1.0 once ar-
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Figure 6.5: Termination of multiple spiral waves in simulations. Top rows: evolution of
four spiral waves and application of four shocks (T=190ms); first frame of each row is
10ms after the most recent shock.
rhythmias were terminated. Statistical analysis on 26 LEAP trials (2 ventricles and 3 atria)
show the average FTE gradually increased in five shocks during successful LEAP. Earlier
shocks can present large variation in FTE whereas the last shock consistently induces high
FTE values among all trials (Figure 6.7A).
The major difference between the successful LEAP and the standard one-shock defib-
rillation is how quickly they induce synchronization. We calculated in Figure 6.6 bottom
panels the time derivative of FTE (dFTE/dt), which indicates how quickly the cells are ex-
cited. In successful LEAP (Figure 6.6), the peak of FTE gradually increased to 1.0 with
the five pulses, but within each pulse, all cells were excited at the same time, revealed
by the larger maximum values and narrow peaks of dFTE/dt. On the other hand, during
the standard one-shock defibrillation (Figure 6.6B), the cells were not synchronized si-
multaneously, as shown by the lower dFTE/dt values associated with shock application.
We performed the two-sample t-test to identify whether the peak dFTE/dt is significantly
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Figure 6.6: Voltage, fraction of tissue excited (FTE) and its time derivative (dFTE/dt) in
experiments. (A) LEAP successfully terminate VF (E=1.4V/cm); (B) Standard one-shock
defibrillation terminate VF (E=4.67V/cm). Red arrows indicate when shocks were applied.
different for LEAP and one-shock defibrillation. We found p = 1 × 10−7 (Figure 6.7B),
which means the probability to find LEAP and one-shock defibrillation have the same mean
dFTE/dt is very small. Therefore, it is statistical significant that LEAP has a larger dFTE/dt
value than one-shock defibrillation. This confirmed LEAP synchronizes tissue faster than
one-shock defibrillation.
6.4 Success rate of LEAP can be improved by adjusting period and timing of shocks
For both atrial and ventricular experiments, we found LEAP works not only for the pacing
cycle length equal to the dominant frequency but also for frequencies that deviated up to
approximately 15-25 percent from the dominant frequency (under- and over-pacing). Fig-
ure 6.8 shows two examples of LEAP termination using a slower period than the dominant
frequency in ventricles (dominant period 120ms, LEAP cycle length 150ms) and atrium
(dominant period 54ms, LEAP cycle length 62ms).
To further study the role of shock timing and LEAP period in relation to the dominant
frequency, we performed numerical simulations using the same setting as Figure 6.5 where
the amplitude and the duration of the shocks were fixed but the pacing cycle lengths were
varied between 50% and 140% of the dominant period (T0) with various timings of the
102
Figure 6.7: Statistical analysis for FTE. (A) Peak of FTE for each shock (from one to five)
during LEAP, averaged among 26 trials (2 ventricles and 3 atria). (B) Peak of dFTE/dt
for one-shock defibrillation (averaged among 19 trials) and LEAP (30 trials). Statistical
significance level is p = 1.0× 10−7.
first shock ranging from 500ms to 1000ms that covers roughly three rotations of the spiral
waves. Movie 8 to Movie 11 show four examples that different combinations of shock pe-
riods and timings lead to various results. Figure 6.9 summarizes the results using different
colors indicating the minimum number of shocks required to terminate the spiral waves for
each period and timing (also see Table 6.1, 6.2). We found it more efficient for terminating
the spiral waves when the shock period was close to the dominant period, in agreement
with the experiments.
The simulations also showed that the influence of timing is more pronounced when
the pacing cycle length is close to the dominant period. Far from T0, such as T = 0.5T0,
ten shocks failed to terminate the spiral waves in all cases regardless of timing. For pac-
ing cycle lengths close to the dominant period (0.9T0 to 1.2T0), first shock’s timings on the
downslope of FTE in general were more successful than those on the upslope. Figure 6.10A
uses different colors to indicate the correlation between FTE and the simulation results of
different first shock timings for T=190ms. Defibrillation is harder to achieve if the first
pulse is delivered when FTE is at a minimum, and it is best to defibrillate just after the FTE
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Table 6.1: Simulation results of the influence of periods and timings on termination of spiral waves. Rows indicate the period of shocks.
Columns indicate the timing of the first shock. T0 is the period of the original spiral waves. N means spiral waves are not terminated after
10 shocks. Y means spiral waves are terminated after 10 shocks and the number in the prentice is the number of shocks that terminate
the spiral waves. Shock strength (E=1.3V/cm) and duration (5ms) are fixed.
XXXXXXXXXXXXT (ms)
tm (ms) 500 520 530 540 570 580 590 600 620 640 660 670 680 690 700 720 730 760
100 (0.5T0) N N N N N N N N
164 (0.8T0) N N N N N Y (10) N N
181 (0.9T0) N N Y (6) Y (5) Y (8) N N Y (10) Y (5)
190 (0.95T0) N Y (7) Y (7) Y (4) Y (3) Y (4) Y (8) Y (5) N N Y (10) Y (9) Y (6) Y (5) Y (4)
201 (T0) Y (7) Y (7) Y (4) Y (5) Y (5) Y (4) Y (4) Y (8) Y (6)
221 (1.1T0) Y (7) Y (6) Y (5) Y (5) Y (4) Y (2) Y (9) Y (6) Y (5) Y (4)
241 (1.2T0) Y (5) Y (5) Y (3) Y (4) Y (3) Y (9) Y (6) Y (5) Y (5) Y (4)
281 (1.4T0) N N N N Y (6) N N Y (7)
Table 6.2: Simulation results of the influence of periods and timings on termination of spiral waves (continue).
XXXXXXXXXXXXT (ms)
tm (ms) 770 780 800 820 840 850 860 870 880 900 920 940 950 960 970 980 1000
100 (0.5T0) N N N N
164 (0.8T0) N N N N
181 (0.9T0) Y (3) Y (5) N Y (3) N N Y (6)
190 (0.95T0) Y (10) Y (5) N N N N Y (10) Y (6) Y (6) Y (5) Y (4) Y (4) Y (5) N
201 (T0) Y (6) Y (5) Y (5) Y (7) Y (7) Y (5) Y (3)
221 (1.1T0) Y (4) Y (3) Y (4) Y (7) Y (7) Y (5)
241 (1.2T0) Y (4) Y (10) Y (8) Y (10) Y (5) Y (2)
281 (1.4T0) Y (10) N Y (10) N
Figure 6.8: Underdrive pacing with LEAP can terminate arrhythmias. Voltage (top) and
fast Fourier Transform amplitude after conversion of frequencies to periods (bottom) for
VF (left) and AF (right).
maximum. Results from other pacing cycle lengths are shown in Figure 6.11. Figure 6.10B
summarizes the results for the FTE upslope (dFTE/dt>0) and downslope (dFTE/dt<0),
respectively, for all pacing cycle lengths. The percentage of trials that successfully ter-
minated the spiral waves within five shocks (green) peaked around the dominant period,
while the percentage that failed to terminate within ten shocks (red) dropped to minimum
(Figure 6.10B and Figure 6.12a). First shocks applied during the FTE downslope had a
higher percentage of arrhythmia termination within five shocks and a lower percentage of
unsuccessful termination within ten shocks than those applied during the upslope, and the
difference peaked around the dominant period (Figure 6.12b). Two-Sample t-tests on per-
centage of trials that successfully terminate arrhythmia within 5 shocks between the trials
with their first shocks applied at the upslope on FTE and the trials with their first shocks
applied at the downslope on FTE also confirmed the difference in efficiency between FTE
upslope and downslope is statistically significant (p = 0.005, n = 10). This indicates that
timing the shocks to coincide with the FTE downslope increases defibrillation efficacy,
particularly as the pacing cycle length gets closer to the dominant period.
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Figure 6.9: Numerical simulations testing different shock periods and timings. Shock pe-
riods vary between 0.5T0 and 1.4T0 (T0 is the dominant period of the spiral waves) and
timings of the first shock range between 500 ms and 1000 ms. Solid circles represent spiral
waves terminated within 10 shocks; their colors indicate the minimum number of shocks
required. Open circles represent LEAP fail to terminate spiral waves. All simulations start
with the same initial conditions.
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Figure 6.10: Role of shock period and timing in LEAP effectiveness. (A) Simulation results
of different timings for T=190 ms. Fraction of tissue excited (FTE) for the spiral waves was
plotted as a function of time (black line). Colored bars indicate timing of the first shock.
Red indicates spirals were not terminated within 10 shocks; blue indicates spirals were
terminated between 5 and 10 shocks; and green indicates spirals were terminated within
5 shocks. Top panel shows five example frames of the spiral waves. (B) Results for FTE
upslope (dFTE/dt>0) and downslope (dFTE/dt<0) respectively for all the pacing cycle
lengths. For example, for T=190 ms, 6.67% /71.4% trials on the FTE upslope/downslope
terminated the spirals within five shocks (green bars in (d)).
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Figure 6.11: Graph demonstration of the results of the numerical experiment investigating
the effects of shock periods and timings. In each trial, 10 shocks were delivered to the four
spiral waves system. Fraction of tissue excited (FTE) for the spiral waves was plotted as
the function of time (black line in each subfigure) for the first 1000 ms. In each subfigure,
the pacing cycle length was fixed. Each bar indicates the timing of the first shock. Red
indicates spirals were not terminated within 10 shocks for that period and timing; blue
indicates spirals were terminated between 5 and 10 shocks and green means the spirals
were terminated within 5 shocks.
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(a) Percentage for upslope and downs-
lope trials
(b) Percentage difference for upslope
and downslope trials
Figure 6.12: (a) Percentage of trials with timings in the upslope (circle) and downslope
(triangle) of FTE that terminated the spiral waves within 5 shocks (green) and failed to
terminate within 10 shocks (red), plotted against the pacing cycle length. The success
(failed) percentage peaked (dipped) around the dominant period of the spiral waves. (b)
The percentage difference between the upslope and the downslope (upslope-downslope) of
terminating within 5 shocks (green) and failed to terminate within 10 shocks (red). The
percentage difference peaked (dipped) around the dominant period and downslope work
better than upslope in terminating the spiral waves.
6.5 Discussion
The main purpose of this chapter is to investigate how LEAP defibrillates differently than
standard one-shock defibrillation. Both experiments and simulations (Figures 6.1, 6.3, 6.5)
showed that LEAP works by gradually synchronizing the electric activity to the same fre-
quency through each additional shock. Because the tissue is synchronized to the same
frequency, both depolarization and repolarization are synchronized. There is no ununi-
form dispersion in refractoriness so additional shocks will not restart arrhythmia. Modified
Kuramoto phase diagrams showed that, during arrhythmias, phase is relatively evenly dis-
tributed, and once LEAP is applied, the phase over the domain is increasingly focused with
each shock. To further quantify this synchronicity, we calculated the fraction of tissue ex-
cited (FTE) as a function of time (Figure 6.6). The FTE peak progressively increases to one
with each pulse for successful LEAP and its derivative indicates how fast the tissue syn-
chronizes. In contrast, during one-shock defibrillation, the FTE upstroke is much slower
compared to LEAP, indicating that all tissue is eventually excited but not at the same time.
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The mechanism of LEAP is different from multi-stage electrotherapy [50], which con-
sists of one to four low-energy biphasic shocks, six to ten ultralow-energy monophasic
shocks, followed by anti-tachycardia pacing (ATP). The three stages of shocks are aimed
to slowly decrease the complexity of the arrhythmia dynamics by first unpinning wave
fronts that maintain the arrhythmia, then preventing the re-pinning of wave fronts to tissue
heterogeneities, and finally annihilating the remaining wave fronts. In short, the method
tries to first simplify the arrhythmia, then pace the arrhythmia driver out of the domain
using ATP [50].
The field strength in LEAP is strong enough to produce AP propagation, hence it is
clearly greater than those used in ”sub-threshold” stimulation, which injects current stimuli
that are too low to elicit a regenerative response of AP propagation in normal resting ven-
tricle muscle. This could interrupt VF by increasing local conduction and/or improving the
coupling between Purkinje and ventricular cells [145]. Sub-threshold effects could add an
additional level of electrical synchronization to break up the arrhythmia thus may further
contribute to the anti-fibrillation actions of LEAP, particularly in the ventricles where the
endocardium contains an extensive network of Purkinje fibers.
LEAP is comparable to anti-tachycardia pacing (ATP) when terminating a single spiral
with advantage over ATP when the spiral is pinned to a heterogeneity [146]. When multiple
spiral waves are presented with higher frequency, some energy increase may be required
for LEAP (Movies 12). Also with shock strength increases, the number of shocks required
to terminate the arrhythmia will decrease (Figure 6.13).
Numerical simulations in this study suggested some ways to improve LEAP by ad-
justing the pacing period as well as the shock timings. The success rate is higher when
the pacing cycle length is close to the dominant period of the arrhythmia. We found that
when the pacing period is too short, most of the tissue is still refractory, which reduces
the amount of tissue that can be captured by the shocks and hence lowers synchronization
effectiveness. When the pacing period is too long, the influence of the previous shock has
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dissipated before the next one, which weakens the collective effect of all shocks. Close to
the dominant period, each pulse happens almost at the same phase of the spirals; thus, the
influence of each pulse can be built on the previous ones, which would be more helpful in
synchronizing the electrical activity. As long as the pacing period is close to the dominant
period, both overdrive and underdrive pacing can terminate arrhythmias. Interestingly, the
simulation shows an asymmetry between underdrive and overdrive: for underdrive pac-
ing, the arrhythmias were terminated in all cases when the pacing cycle length was up to
20% above the dominant period, whereas for overdrive pacing, the spiral waves were not
terminated in 28% cases when the pacing cycle length was only 5% below the dominant
period. In simulations, spiral waves in rigid rotation mode tend to follow the highest pos-
sible frequency before conduction block, whereas in meander mode, the frequency can be
lower [147]. Therefore, in our simulations where the spiral waves were in rigid rotation
mode, it was harder to excite the tissue when the pacing frequency was higher, whereas
in experiments, where the spiral waves were usually experienced a combination of rigid
rotation and meander, the pacing cycle lengths had more freedom to vary.
The computer simulations also suggested a higher success rate when the first shock
was applied at the downslope of the fraction of tissue excited (FTE) curve. Note, however,
that this is only based on the correlation between FTE and the timing of the first shock.
Nevertheless, our results seem to agree with those of Turner et al. [148], where termination
of tachyarrhythmia in humans was most likely when delivered a few milliseconds after the
ECG peak. A simulation study by Rantner et al. [149] proposed applying shocks at the
times when tissue excitable volume is maximum (the excitable gap is largest) instead of
at a fixed pacing cycle length. Although this protocol can effectively convert VF to VT, it
does not always terminate it, and it therefore requires a second stage of low-voltage stimuli
to terminate the arrhythmia. It also adds extra difficulty to experiments when the pacing
cycle length is not fixed and each shock must happen when the least amount of tissue is
excited. Our study only aimed to improve the success rate of LEAP based on its original
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Figure 6.13: Average number of shocks as a function of shock strength to terminate the 4-
sprial arrhythmia in simulations. Shock period is 221ms, 10% above the dominant period
of the spirals. For each shock strength, 4 numerical simulations were performed, each with
a different timing of the first shock. Then the number of shocks was averaged among the 4
trials. Error bar represents the standard deviation.
protocol instead of looking for optimal solution so that it can be easily implemented in
future experiments.
6.6 Limitation
This chapter only tested arrhythmias in isolated atria and separated right and left ventricles
(for better optical mapping visualization) but not in full hearts. We only performed 2D
simulations because 2D shells can support complex dynamics and the atrial wall is usually
only a few millimeters thick. However, we still need to test the shock timing hypothesis
using more complicated models that display more complex breakup and different excitable
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gaps. Only human atria model was simulated here. We also need to test the theories on
ventricle models.
One major finding from this chapter is that synchronization is the main mechanism for
LEAP to terminate arrhythmia. We used Kuramoto phase plot to demonstrate that. More
rigorous analysis is needed for the future work. For example, we should calculate the




EFFECTS OF HETEROGENEITIES ON DEFIBRILLATION
In this Chapter, we explored how heterogeneities affect defibrillation results using WebGL
accelerated simulations. The heterogeneities we are interested in are blood vessels. In 2D,
we first compared the simulations with experiments, then we used the validated model to
investigate factors affecting defibrillation success rates. In 3D, we verified the hypothesis
that the low-energy shocks terminate fibrillation by detaching the vortex filaments from
depolarization surface in realistic 3D structure.
7.1 Simulation setup
For defibrillation simulations in this chapter, we solved monodomain equations (Eq. 3.2)
with boundary conditions as Eq. 3.4.
For the 2D situation, the simulation domain is a square withD/Cm = 1.0×10−3cm2/ms.
Non-conductive circles represent blood vessels on the tissue. Figure 7.2 shows an example
of the 2D domain with 3% of the total areas being blood vessels. 5% and 8% of vessels are
also being used. For each percentage, up to five structures with vessels located at different
random positions are generated for simulations.
We used the Ten Tusscher model [75] and the Fenton-Karma-3V model [81] as ionic
models (specified in each case). Explicit Euler and center difference schemes are used for
the time and spatial integration and the resolutions are ∆t = 0.01ms and ∆x = 200µm.
7.2 Validating virtual electrodes from blood vessels
The size distribution of the blood vessels follow the power law as the experiments [3]. In
Figure 7.2, R is the vessel radius. There are more smaller vessels and fewer larger ones.
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Figure 7.1: Example of 2D simulation domain. Grey areas are conductive tissue with
D/Cm = 1.0× 10−3cm2/ms and black circles represent non-conductive vessels with D =
0. The domain size is 20cm by 20cm.
Figure 7.2: The size distribution of blood vessels following the same power law as experi-
ments: p ∼ R−2.75.
The distribution density follows p(R) ∝ R−2.75.
In this section, we verified that two characteristics of virtual electrodes (minimum ra-
dius and excitation time) of our numerical simulations follow the power law close to the
experimental results.
7.2.1 Minimum Radius
For a given electric field strength, there exists a minimum radius of the blood vessels to
generate virtual electrodes. Figure 7.3 demonstrates this. The two blood vessels with
different sizes are subjected to the same electric field strength. On the left, the vessel is
smaller than the minimum radius so no excitations are generated while on the right, the
116
Figure 7.3: Vessel size affects the generation of virtual electrodes. The same electric field
strength is applied to both vessels. The smaller vessel (R = 0.5mm) does not generate
excitation while the larger one does (R = 1.7mm). The size of the tissue is 4cm×4cm
vessel is large enough to produce a propagation wave.
From theory, the minimum radius is inversely proportional to the electric field strength
(Rmin ∝ E−1) for large electric field[3]. We performed numerical experiment for the
Ten Tusscher model. In the simulation, for a given electric field strength, we gradually
increase the size of the vessel until an excitation wave is generated (Figure 7.3). We plot the
minimum radius as a function of electric field strength and fit the curve into log(Rmin) =
αlog(E) + β using MATLAB polyfit function and we get α = −1.0247, β = −3.5625
with r2 = 0.9813, which is close to the theoretical. However, there is a deviation. The
theory for the power law breaks down when the electric field is small because there is a
finite excitation threshold for a cell. It will also break down when the radius of the vessel
is small because the resolution and the size of the cell is finite. These can both contribute
to the discrepancy between the theory and the simulation.
7.2.2 Excitation Time
Next we verified the relation between the time for the excitations to propagate through the
whole domain (τ ) and the electric field strength (E).
We assume the number of virtual electrodes is proportional to the number of the blood
vessels. By integrating the distribution density function of blood vessels we can get the
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Figure 7.4: Fitting of the minimum radius to generate virtual electrode to a power law of
the electric field strength. The power is -1.02, close to the theoretical value -1.





Then we assume the excitation from virtual electrodes propagate uniformly with a con-
stant speed v, in time τ , it will occupy the volume of V = ρ4
3
π(vτ)3, therefore we can
calculate the excitation time τ from the total volume V of the heart based on the p(R)
acquired from experiments. This is the τ value in theory.
On the other hand, we can measure in experiments the total time it takes for the exci-
tation to propagate through the surface from the optical mapping experiments. The theory
and the experimental results agree with each other very well with τ ∝ E−0.87 [3].
We verified the excitation time for the Ten Tusscher model with the domain size of 4 cm
× 4 cm, which is similar to the tissue size in experiment [3]. The radii of the vessels range
between 0.04 mm to 0.8 mm with spatial resolution of 0.04 mm. The results are shown in
Figure 7.5
Circles are values from numerical experiments, averaged among 5 structures. Error
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Figure 7.5: The fitting of the excitation time as a power law of the electric field strength for
the Ten Tusscher model. The power of the fitting is close to the experimental value -0.87
for the three different numbers of vessels.
bars are standard deviations. Different colors (blue, red and green) are for different blood
vessel numbers. The total area of blood vessels (ρ) is 2%, 5% and 10% of the total area
of the square domain. The three curves do not fit into power law well if all the data points
are included in the fitting. This is because when E keeps increasing beyond a threshold,
an activation delay required to generate a propagating action potential thus τ reaches its
nonzero lower bound.
However, if we only fit the curve within the experimental electric field range (magenta,
cyan and black curves), which is between 0.5 and 2.5 mV [3], then the curves can be fit into
τ = βEα with α being -1.0, -0.90 and -1.0 for ρ = 0.02, 0.05, 0.1, which are much closer to
the theoretical value (Table 7.1). This means our simulations can reproduce the excitation
time within the experimentally tested E range, and provide additional information in the
range that is hard to test in experiments.
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7.3 Comparison of the defibrillation success rate between LEAP and the one-shock
defibrillation
We initialized the spiral waves using the S1-S2 protocol on a 20 cm × 20 cm domain and
we induced the wave breaks by choosing ten random sites to excite. After sufficient wave
breaks, we applied either the one-shock defibrillation or LEAP. Both LEAP and the one-
shock defibrillation used biphasic shocks. For LEAP, pacing periods of 1.1T0, 1.5T0 and
2.0T0 were tested, T0 being the dominant period of the fibrillation. For each shock strength,
we calculated the defibrillation success rate for 40 trials with randomized initial conditions.
Figure 7.6 shows the comparison of the one-shock defibrillation and LEAP for two
different structures. 3% of the total area is blood vessels in both structures but vessels are
located at different random locations. In general, LEAP has a higher defibrillation success
rate than the one-shock defibrillation. For example, for the first structure, to achieve 80%
defibrillation success rate, the one-shock defibrillation needs electric field strength of at
least 7.5 V/cm while LEAP with the period of 2T0 needs 4 V/cm, which is 72% of energy
reduction per pulse.
The performance of LEAP depends on the period of the shocks. For both structures,
the longer periods work better than the shorter ones. This can be explained by Figure 7.7,
which shows the LEAP defibrillation success rate as a function of the number of shocks for
pacing period of 1.5T0 (Figure 7.7a) and 2.0T0 (Figure 7.7b). Solid lines are for structure
from Figure 7.6a and dotted lines are for structures from Figure 7.6b. Different colors
indicate different electric shock strengths. For both structures, stronger shocks have higher
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(a) Structure 1 (b) Structure 2
Figure 7.6: Comparison of defibrillation success rate between one-shock defibrillation and
LEAP for two different structures with blood vessels located at different random locations.
LEAP with longer pacing period has higher defibrillation success rate than the one with
shorter pacing period and one-shock defibrillation.
defibrillation success rates. When the pacing period is 2.0T0, the success rate increases
with each additional shock while when the period is 1.5T0, the success rate decreases at
the third shock. This is because different regions on the domain has different frequencies.
When the period is short, even though it is above the dominant period, there will be regions
that have periods longer than the dominant period. In those regions, the wave front can
catch up and interact with the wave back of the previous excitation, which can re-initiates
wave breaks and make defibrillation harder. That’s why in our simulations, LEAP works
better with longer periods.
7.4 Factors affecting defibrillation success rate
First, we explored the effects of number of heterogeneities on one-shock defibrillation suc-
cess rate. Five 20 cm × 20 cm domains with blood vessels located at random spots were
generated for three different number of blood vessels each: 3%, 5% or 8%. We calculated
the defibrillation success rate for each structure using the Ten Tusscher model and average
among the five structures to get the averaged defibrillation success rate. Figure 7.8 shows
the results. For a given structure, the defibrillation success rate increases to 1.0 when the
121
(a) T = 1.5T0 (b) T = 2.0T0
Figure 7.7: LEAP defibrillation success rate as a function of different number of shocks for
pacing period of 1.5T0 and 2.0T0. For T = 2.0T0, the defibrillation success rate increases
when the number of shock increases. For T = 1.0T0, however, the defibrillation success
rate decreases at the third shock due to the re-initiation of spiral waves.
electric field strength increases. For the same electric field strength, domains with more
blood vessels have higher defibrillation success rate. This is because more blood vessels
and stronger electric field strength will produce more virtual electrodes and therefore higher
success rate.
Next, we varied the size of the domain from 7.5 cm to 15.0 cm. Here the Fenton-
Kamar-3V model is used. The choice of the model and the domain size is based on the
feature of the fibrillation and the number of spiral waves we want to fit on the domain. We
chose Fenton-Karma-3V model because its parameters have a highly-breakup regime that
can fit 5 waves on the smallest domain we tested here and 20 waves on the largest domain.
For each domain size, the area of blood vessel is fixed to be 3%. The maximum/minimum
radius and the size distribution of the blood vessel is also the same for each domain size.
Figure 7.9 shows the results. Figure 7.9a plots the success rate as a function of the electric
field strength. Figure 7.9b plots the success rate as a function of the tissue size.
Similar to Figure 7.8, the defibrillation success rate increases to a plateau value when
the electric field strength increases. However, the plateau values do not always equal to 1.0.
With increasing tissue size, the plateau success rate decreases. This is because the model
parameters are in a highly breakable regime. Even though the strong shocks can excite
the whole domain, slight discrepancy in the excitability in different regions can cause re-
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Figure 7.8: The effects of number of blood vessels on defibrillation success rate. When
the number of heterogeneity increases, the defibrillation success rate increases. The Ten
Tusscher model is used.
initiation of spiral waves.
For a given electric field strength, the defibrillation success rate decreases when the tis-
sue size increases and the decreasing rate is almost linear. This is because for larger tissue,
more waves can fit in the domain and the number of spiral waves is linearly increasing with
respect to the tissue size 7.9c. More waves make it harder to defibrillate.
7.5 Electrode shapes affecting defibrillation results
All the defibrillation simulations we have done so far are with two plane electrodes so the
electric field is uniform in between. In real life, defibrillators, especially the implantable
ones, do not take form of plane electrodes. The implantable cardioverter defibrillator (ICD)
usually applies the electric shocks between one or several electrodes that are implanted in
the heart, usually 1 to 2 millimeters in diameter, and an oval shaped can, about 5 to 7
centimeters in length. In this section, we discuss how the shape of electrodes affect the
defibrillation results.
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(a) S.R. as a function of E field (b) S.R. as a function of the tissue size
(c) S.R. as a function of the number of
spiral waves
Figure 7.9: The effects of tissue size on defibrillation success rate. The defibrillation suc-
cess rate decreases when domain size increases and the decreasing rate is linear for all
electric field strength. Fenton-Karma 3V model is used.
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Figure 7.10: The setup of the electrodes
7.5.1 Electrodes setup
Inspired by the ICDs, we set one electrode to be a point electrode with a small radius of
1 mm and the other electrode takes a few different shapes: either a plane or a semi-sphere
with a radius of 4cm that can be either concave or convex. The distance between the two
electrodes is 30cm. The ”heart tissue” is a 2D slab with the dimension of 20 cm × 20
cm, as in our previous Ten Tusscher simulations, located in the center between the two
electrodes. We set the electric potential on the point electrode to be -10 V and the potential
on the spherical electrode to be 0 V to create the electric field in between.
We built the electrodes setup in COMSOL. Figure 7.10 shows an example. In COM-
SOL, we used the Electric Current (ec) mode to solve the electric potential and the electric
field in the 3D 30 cm × 30 cm × 30 cm space using the finite element method with an
extremely fine mesh. A thin slab of heart tissue is placed in the center. The potential on the
two electrodes are fixed to two constant values to create electric field in between. Boundary
conditions everywhere else is zero-flux. Then we output the electric field in the heart tissue
region and use that as the electric shocks in the 2D Ten Tusscher model simulation.
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(a) Plane-Point electrodes (b) Sphere-Point electrodes
Figure 7.11: Method of images for two electrodes configurations
7.5.2 Method of images
We also used the method of images to calculate the theoretical electric potential and electric
field in two cases: (1) one point electrode and one infinite plane electrode (Figure 7.11a);
(2) one point electrode and one convex spherical electrode (Figure 7.11b).
For the Plane-Point electrode setup, the infinite plane is grounded and the point elec-
trode with r0 = 1mm has the electric potential of −2V0. The distance between the plane
and the point is L (Figure 7.11a). We make the approximation that charge is uniformly
distributed on the point electrode and the charge density is −σ. We can make this approx-
imation because L >> r0. From the symmetry, we know this system is equivalent to an
image point electrode located on the other side of the plane with charge density +σ to make
the potential equal to zero on the plane. Assuming the distance L is much larger than r0, we
can calculate the potential on the point electrode due to the charge on it and on the image
point electrode:





























Treat both the point electrode and the image point electrode as point charges. The electric
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The net electric field is ~E = ~E+ + ~E−.
Similarly, for the Sphere-Point electrode setup, the sphere is grounded and the point
electrode has an electric potential of−2V0 (Figure 7.11b). Assume a uniform charge distri-
bution on the point electrode with the charge density of σ. An image electrode with charge




and σ′ = R
R+L
σ = ασ, R being the radius of the sphere. To maintain the potential on the
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7.5.3 Compare the results between COMSOL and the method of images
We set V0 = 5V in both COMSOL and the method of images and calculated the electric
potential between the two electrodes. Figure 7.12 shows the results. The potential distribu-
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tion follows the same trend. There is a discrepancy between COMSOL and the method of
images and the difference is less than 10%.
Then we output the electric field in the region where the heart tissue is supposed to be
and we rescaled it so that the mean value of the magnitude of the electric field on the tissue
domain is the field strength that we tested in simulations in the previous section. We tested
the defibrillation success rate for the one-shock defibrillation and plotted it as a function of
average E field strength for different electrode configurations. The Ten Tusscher model is
used with 5% blood vessels.
Figure 7.13 shows the results. The blue line is the defibrillation result for two infinite
plane electrodes (same as in Figure 7.8). The red and the green lines with triangle markers
used the electric field strength from the Plane-Point and the Sphere-Point electrode con-
figurations from COMSOL. The red and the green lines with circles used the electric field
from the method of images.
The Plane-Plane configuration has the highest defibrillation success rate. It is because
the electric field in between is uniform. It is easier to get more excitations for a given E
field strength. The Plane-Point works better than the Sphere-Point configuration, but the
difference is not much. There is a clear discrepancy between COMSOL and the method
of images. In order to understand this, I plotted in Figure 7.14 the distribution of the mag-
nitude of the E field strength for (i) Plane-Point configuration in COMSOL (top left), (ii)
Plane-Point configuration in the method of images (top right), (iii) Sphere-Point config-
uration in COMSOL (bottom left), and (iv) Sphere-Point configuration in the method of
images (bottom right). In all cases, the average E field magnitude is the same. Within the
same configuration, the COMSOL distribution is more narrow than the method of images.
This means the E field is more uniformly distributed, similar to the Plane-Plane configura-
tion. If the distribution is wide, when part of the domain is applied by a strong E field, the
other part is under a weak field strength. This will cause excitations of only a part of the
domain, therefore failed termination of fibrillations.
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(a) COMSOL: Plane-Point (b) COMSOL: Sphere-Point
(c) Method of image: Plane-Point (d) Method of image: Sphere-Point
(e) Difference: Plane-Point (f) Difference: Sphere-Point
Figure 7.12: The electric potential of Plane-Point and Sphere-Point electrode configuration
solved using COMSOL and the method of images and compare the difference between the
two methods. The difference is less than 10%
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Figure 7.13: The defibrillation success rate for different electrode configurations. The
Plane-Plane configuration has the best defibrillation results. Within COMSOL/method of
images, there are not much difference between the Plane-Point and Sphere-Point electrode
configuration but there’s a clear difference between COMSOL and the method of images.
7.6 Low energy shocks terminate arrhythmia by detaching vortices’s filaments from
depolarized surface
One hypothesis for the low-energy shocks to terminate fibrillation is that the shocks detach
the vortices filaments from the depolarized surface [150]. Previous simulations have shown
this in simplified geometries such as cylinders and hemispheres that represent heart tissue.
Here we demonstrate it in a realistic 3D structure.
A canine left ventricle structure was extracted from micro-CT scans. Blood vessels
imbedded in the tissue was treated as inexcitable medium. The size of the 3D structure is
3.7× 2.15× 4.76 cm3 (x-y-z) and the grid size is 256× 128× 128. Figure 7.15 shows the
structure. Note that the resolutions in the x and the y directions are comparable and they
are much higher than the z direction due to the resolution of the original CT scans. Time
resolution is 2.0 × 10−2 ms. Fenton-Karma 3V model with none-breakup parameters was
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Figure 7.14: The magnitude of E field distribution for Plane-Point (top) and Sphere-Point
(bottom) electrode configurations in COMSOL (left) and the method of images (right). The
E field strength is more homogeneous in the COMSOL simulation than in the method of
images.
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Figure 7.15: 3D canine left ventricle structure with blood vessels.
used.
Figure 7.16 shows the evolution of the scroll waves (left panels) and their filaments
(right panels) before and after the shock.
One spiral wave was initiated and it broke into two counter-rotating scroll waves. The
two filaments run in parallel connecting epicardium (front surface) and endocardium (back
surface) (Figure 7.16a). Then a monophasic shock with the strength of 1 V/cm and the
duration of 5 ms is applied. During the shock, the epicardium is depolarized. Figure 7.16b
shows 2 ms after the end of the shock. Figure 7.16c and Figure 7.16d shows 15 ms and
40 ms after the shock. The end of the filament formerly connected to the epicardium is
detached and connected to the top/bottom surface. This demonstrates the ability of the
shock to disconnect filaments from the surface depolarized by the shock. Then the two
filaments shrink and disappear (Figure 7.16e). This confirmed Otani’s theory that low
energy shocks can transform all filaments into shapes that tend to shrink and disappear
thereby terminating all the vortices and associated turbulence.
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(a) 0ms (b) 2ms
(c) 15ms (d) 40ms
(e) 65ms
Figure 7.16: Effects of the electric shocks on vortices’s filaments. The time in each figure
is the time after the shock. The shock disconnected the filaments from the depolarized
surface (epicardium, the front surface) and annihilate the filaments.
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7.7 Conclusion and limitation
The main purpose of this chapter is to use WebGL-accelerated simulations to investigate
how heterogeneity affects defibrillation results. We first verified that the simulations can
reproduce two important characteristics associated with virtual electrode: the minimum
radius of the heterogeneity to generate virtual electrode and the excitation time for the
wave to propagate through the whole domain as a function of electric field strength. Then
we showed that LEAP works better in simulations with longer pacing period. This is be-
cause longer period shocks are less likely to re-initialize spiral waves when the spirals
are in a highly-breakable regime. Furthermore we demonstrated that larger domains with
more waves fit in them are harder to defibrillate. Then using COMSOL simulations and
the method of images, we showed that the uniform electric field have the best defibrilla-
tion results and except for Plane-Plane electrode configurations, other shapes of electrodes
do not change the defibrillation results much. Finally, we conducted 3D simulations to
demonstrate the termination of fibrillation by detaching the vortices’s filaments from the
depolarized surface.
From these results, we suggest a few tests for future LEAP simulations and experi-
ments:
(1) The pacing period should depend on what kind of spiral waves the system has. If
the spiral is in steady rotation mode or the system has a narrow frequency spectrum, the
pacing period should be close to the dominant period. If such shocks re-initiate fibrillation,
long pacing period should be considered.
(2) Reducing the number of spiral waves could be the first stage of LEAP before termi-
nating them all. Other pacing protocols such as ATP could be combined to LEAP for this
purpose.
(3) When design and test the shape and the position of electrodes for delivering shocks,
the ones that ensure a uniform electric field distribution (such as large plane electrodes)
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should have better defibrillation results.
Limitations and future work:
(1) In this chapter, we only considered blood vessels as the heterogeneity. Caldwell et
al. used 3D optical mapping showed that virtual electrodes are generated due to the lateral
cell uncoupling in the direction of the electric field instead of at large blood vessels when
the shock strength is so low that it doesn’t produce an activation wave [151]. We should
consider the effects of not only the tissue level heterogeneity such as blood vessels and
fiber rotations, but also cellular level heterogeneity such as cellular uncoupling.
(2) There is a noticeable difference in the results between COMSOL and the method
of images. One possible reason could be the setup of the COMSOL simulation is not
comparable to the method of images. For example, the computation domain in COMSOL
could be set to be larger to reduce the boundary effects. More careful verification is needed.
(3) When we tried to fit the ”minimum radius” and the ”excitation time” into power
laws, we observed a difference between the simulation and the theory. We provided some
explanation why the theory breaks down. Rigorous algorithms could be used for testing




The main goal of this thesis is to investigate the mechanism of low-energy defibrillation
and to improve it. The thesis can be divided into three parts. The first part is background,
literature review and problem description. The second part is validation of two aspects of
numerical models: contraction and calcium dynamics. The third part focus on the mecha-
nism of LEAP and the effect of heterogeneities on defibrillation results.
In Chapter 4, we developed a systematic methodology to implement contraction into
electrophysiology models. We found that EP models with dynamic calcium troponin buffers
are better candidates to implement contraction. The inclusion of contraction does not dis-
turb properties in the original models and the contraction behavior of post-extrasystolic
potentiation fits experiments better.
In Chapter 5, we characterized with high spatio-temporal resolution the development of
discordant alternans patterns in transmembrane voltage (Vm) and intracellular calcium con-
centration ([Ca2+i ]) as a function of pacing period in rabbit hearts. Then we compared the
dynamics to that of Sato et al. model. We found that in experiments, the nodal lines of CaD
alternans have a steeper slope than those of APD alternans, but not as steep as predicted
by numerical simulations in rabbit models. Alternans in CaD have nodal lines that are
about an order of magnitude steeper compared to those of APD alternans. Current action
potential models lack the necessary coupling between voltage and calcium compared to
experiments and fail to reproduce some key dynamics such as, voltage amplitude alternans,
smooth development of calcium alternans in time, conduction velocity and the steepness of
the nodal lines of APD and CaD.
In Chapter 6, we investigated the mechanism of LEAP with both ex vivo experiments
and simulations. We induced atrial and ventricular fibrillation in isolated canine hearts and
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applied LEAP and standard one-shock defibrillation to terminate the arrhythmia. We simu-
lated the arrhythmia and LEAP using a 2D bidomain human atrial model. Both experiments
and simulations verified synchronization from virtual electrodes is the key mechanism for
termination of arrhythmia by LEAP using modified Kuramoto phase plots and fraction of
tissue excited (FTE) plots. We also observed in simulations that LEAP is more effective
when the shock period is close to the dominant period and the first shock is delivered when
FTE is decreasing.
In Chapter 7, we investigated the effect of multiple factors on defibrillation. We showed
that LEAP works better in simulations with longer period. We demonstrated that larger
domains with more waves fit in them are harder to defibrillate. Then using COMSOL
simulations and the image charge method, we showed that the uniform electric field have
the best defibrillation results and except for Plane-Plane electrode configurations, other
shapes of electrodes do not change the defibrillation results much. Finally, we conducted
3D simulations to demonstrate the termination of fibrillation by detaching the vortices’s






A.1 Step 0: Handling models that already have contractions.
If the model has NL96 contraction then we only need to take that out. For example, Mat-
suoka etal 2003 has NL96 contraction. We eliminate the four troponin states in NL96 and
replace them with the single-state dynamic equation for CaTRPN like Eq. 4.3 and set Kon
and Koff to the values of Y1 and Z1.
If the model has contraction but not the NL96 one, we first take out the original con-
traction then implement NL96. For example, Iribe etal 2006 model has Rice1999 contrac-
tion. Rice mechanics model has six tropomyosin/cross-bridge states. The transform rates
among these six states are related to CaTRPN. Their CaTRPN is expressed by a single-
state dynamic equation like Eq. 4.3 with a dynamic Koff dependent on force. To take out
contraction from Iribe etal 2006, we eliminate the six tropomyosin/cross-bridge states and
set Koff for CaTRPN to a constant value by fixing the force in the Koff expression to half
of its maximum value. After taking out Rice1999 contraction, follow Step 3 in the NL96
contraction implementation flowchart to implement NL96.
A.2 Step 1: Add instantaneous CaTRPN buffer
If the model has one general Ca2+ buffer (referred as General) representing the average
effect of all intracellularCa2+ buffers (e.g. TenTusscher etal 2006 and Fink etal 2008), we
split the general buffer into two parts: CaTRPN and Other. We keep Kd,TRPN and Kd,Other
to be the same asKd,General in the original model so that the Ca affinity of the instantaneous
buffer will be retained. Bmax,TRPN was set to be 0.07mM, which is a standard value in
most models. Bmax,Other = Bmax,General − Bmax,TRPN so that the concentration of the
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total intracellular Ca2+ buffer is the same as in the original model. If the model has other
Ca2+ buffers (such as CMDN) but no CaTRPN (e.g. Fox etal 2002), we keep the other
buffers unchanged and add a CaTRPN buffer. For the new CaTRPN buffer we also set
Bmax,TRPN = 0.07mM and Kd,TRPN = 0.6µM , which are both common values in many
models.
A.3 Step 2: Change the instantaneous intracellular CaTRPN into a dynamic buffer.













ICatotal is the total intracellular Ca
2+ current; β is the instantaneous buffer factor; index j rep-
resents each type of intracellular Ca2+ buffer; Bmax,j and Kd,j are the total concentration





= β′(ICatotal − ICaTRPN (A.2a)










2+]i(Bmax,trop − [CaTRPN ])−Koff [CaTRPN ]
(A.2c)
in which J’ goes through all Ca2+ buffers except for CaTRPN.
To change instantaneous CaTRPN into a dynamic buffer, we delete the term corre-
sponding to troponin in the instantaneous buffer factor β and subtract the CaTRPN current
from the total intracellular Ca2+ current. The dynamic equation for CaTRPN represents





The way to choose Kon and Koff here is not unique as long as
Koff
Kon
= Kd in the original
model. We choose Koff =
√
σKoff,s and Kon = 1/
√
σKon,s, where s indicates the values




[Ca2+]i(t=0) and other variable values are quiescent values of the original model.
[CaTRPN]i(t=0) is the value that makes
d[CaTRPN ]i
dt







A.4 Step 3: Split the single state dynamic CaTRPN in Step 2 (or original model) into
2 states: with (TCa*) or without (TCa) cross-bridges.




= β′(ICatotal − ICaTRPN (A.4a)























2+]i[T ]− Z1[TCa])− (Y2[TCa]eff − Z2[TCa∗]) (A.4e)
d[TCa∗]
dt
= −(Y3[TCa∗]− Z3[T ∗][Ca2+]i) + (Y2[TCa]eff − Z2[TCa∗])
− Yd(dX/dt)2[TCa∗] (A.4f)
[T ] = [Troponin]total − [T ∗]− [TCa]− [TCa∗] (A.4g)
If the original model has dynamic equation for all buffers then there will be no instanta-
neous buffer factor β so simply ignore it in the implementation steps for this kind of model.
A.4.2 Initial conditions
[Ca2+]i(t=0) and other variable values are quiescent values of the original model.









[CaTRPN](t=0) = [TCa](t=0) + [TCa∗](t=0), calculated from the above step, approxi-
mately equal to the value of [CaTRPN] in quiescent state if the original model has [CaTRPN].
There are multiple Kon and Koff . They are kept the same as original NL96 paper [106]
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except for Y1 and Z1, which are chosen to match the values of Kon and Koff from the
original model (if the original model has dynamic CaTRPN) or from Step 2.
A.5 Implementation of instantaneous NL96 into models with instantaneous CaTRPN
The original NL96 model can be written as dSj
dt
= fj . Sj = [T ], [T ∗], [TCa], [TCa∗] for
j = 1,...,4. The equation for [T ] can be replaced with the conservation of total troponin
concentration: [T ] + [T ∗] + [TCa] + [TCa∗] = [Troponin]tot.
For the instantaneous NL96, we set dSj = 0 and solve for [T ], [T ∗], [TCa], [TCa∗].
The matrix form is Ax = b, in which x = ([T ], [T ∗], [TCa], [TCa∗])T ,























1 1 1 1

expo = exp(−R(L − La)2). At each time step, solve x = A−1b to get [T ], [T ∗], [TCa],
[TCa∗].
To implement this instantaneous NL96 into EP models with instantaneous CaTRPN,





























BTCa = [T ] + [TCa], BTCa∗ = [T ∗] + [TCa∗], Kd,TCa = Z1/Y1, Kd,TCa∗ = Y3/Z3
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APPENDIX B
CA2+ AND CONTRACTION RESULTS FOR ALL 14 EP MODELS























Model with NL96 contraction
|∆[Ca2+]isystolic|=6.67%



















Model with NL96 contraction
























Model with NL96 contraction
|∆[Ca2+]isystolic|=1.02%











































Model with NL96 contraction
|∆[Ca2+]isystolic|=1.60%











































Model with NL96 contraction
|∆[Ca2+]isystolic|=62.8%



















Model with NL96 contraction































Model with NL96 contraction




















































Model with NL96 contraction
|∆[Ca2+]isystolic|=64.4%











































Model with NL96 contraction
|∆[Ca2+]isystolic|=33.3%



















Model with NL96 contraction
|∆[Ca2+]isystolic|=33.3%
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B.4 Postextrasystolic potnetiation curve (PESPC, circles o) and extrasystolic me-
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APPENDIX C
COMPARISONS BETWEEN NL96 AND TWO OTHER CONTRACTION
MODELS
C.1 Comparison between NL96 and RWH99
Since Iribe etal 2006 has RWH99 in the original version, we compare the contraction dy-
namics between Iribe etal 2006 with NL96 and with RWH99. Results of Iribe etal 2006
with NL96 have been presented in previous figures while the results for Iribe etal 2006
with RWH99 are in Fig. C.1. The two models show very similar characteristics except for
two parameters: to,pes and Tmrc,pes.
The PESI-axis interception to,pes increases monotonically with respect to ESI for Iribe etal 2006
with RWH99 while it is not monotonic for NL96, therefore MRCpes curves cross each
other at low PESI values. In addition, the to,pes value range for NL96 is much lower than
RWH99, whose value is closer to Yues experiment.
However, Iribe etal 2006 with NL96 is more consistent with the experimental values of
Tmrc,pes compared to the corresponding RWH99 model. The deviation in Tmrc,pes is smaller
for NL96 and more data points fall into Yues mean±SD range than RWH99.
Therefore, under the isometric conditions, we observed no significant differences be-
tween NL96 and RWH99 under the scope of this study in the sense that each model matches
some parameters with experiments better than the other in this study.
C.2 Comparison between NL96 and instantaneous NL96
Including NL96 contraction into EP models with instantaneous or no CaTRPN (Type Four
and Five) changes the original Ca2+ shape. To provide evidence that the deformed Ca2+
transients are not the direct cause for the poor contraction behavior of this type of model,
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Figure C.1: Dynamics of the Iribe etal 2006 with RWH99 contraction: (a) Priming ; (b)
postextrasystolic potentiation in Ca2+; (c) postextrasystolic mechanical restitution curves
(MRCpes); (d) postextrasystolic potnetiation curve (PESPC); (e) minimum-value axis in-
tercept curve (to,pes); (f) Time constant for curve MRCpes (Tmrc,pes).
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we introduce the instantaneous NL96 contraction model by setting the dynamic equations
in the NL96 model to be instantaneous, i.e. to set the right side of ODEs (Eq. 4.2) to be
zero. In this way, all four states associated with the CaTRPN are instantaneous variables
expressed by algebraic functions. Therefore we can easily incorporate them into EP mod-
els with instantaneous or no CaTRPN (Type Four and Five). Detailed steps are shown
in A. In this models construction, the time delay between Ca2+ and the four states of tro-
ponin buffer disappears. Figure shows results after implementing the instantaneous NL96
into Ohara etal 2011. They are similar to those of the Ohara etal 2011 model with NL96
implemented except that MRCpes and PESPC are shifted upward and to,pes is shifted right-
ward due to the elevation of systolic [Ca2+]i. In a word, after the implementation of the
instantaneous NL96, the Ca2+ transient is hardly altered from the original model yet the
contraction results are still not consistent with Yues experiment in multiple parameters.
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Figure C.2: Dynamics of the Ohara etal 2011 with instantaneous NL96: (a) Priming
Ca2+; (b) postextrasystolic potentiation in Ca2+; (c) postextrasystolic mechanical resti-
tution curves (MRCpes); (d) postextrasystolic potentiation curve (PESPC); (e) minimum-
value axis intercept curve (to,pes); (f) Time constant for curve MRCpes (Tmrc,pes)
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APPENDIX D
VARYING PHYSIOLOGICAL PARAMETERS IN CONTRACTION
IMPLEMENTATION
D.1 Pacing frequency
In our studies we used 500ms as the priming pacing cycle length for all the models for
two reasons. First, its close to the pacing period in Yues experiment [], with which we
compared our simulation results. Second, we wanted to compare all the models uniformly
with one prime period (PP) and 500ms is close to the physiological heart rate of dogs and
its between that of guinea pigs and humans. Nevertheless, to check and verify the valida-
tion of our results at 500 ms, we performed additional simulations on the Grandi etal 2010
(human) model using 850ms as the priming period. Figure D.1 compares the MRCpes,
PESPC, to,pes, Tmrc,pes and the PESP in Ca2+ of the Grandi etal 2010 model when using
a pp=500ms (left panels) and 850ms (right panels). The Grandi etal 2010 model shows
qualitatively similar behaviors for 850ms comparing with 500ms and the difference in the
amplitude of MRCpes and PESPC is directly related to the change in the normalization.
Therefore we believe that our results using uniform priming period of 500 ms for all mod-
els is a good compromise and does not change quantitatively the PESP behaviors when




















It has been shown that changes in temperature can produce large effects in the dynamics
of cardiac tissue [153, 154, 155, 156]. Because we are combining a room temperature
contraction model (NL96) with body temperature (37C) EP models, we wanted to inves-
tigate how temperature could influence our results. For this we reversed the approach of
Matusoka etal 2003, where they modified the NL96 to physiological temperatures by mul-
tiplying the rate constants (Y2, Z2, Y4, Yd) by three [76]. We proceeded to change the rate
constants in Matsuoka etal 2003 back to the original values in NL96 and compare their
dynamics. Figure D.2 shows MRCpes, PESPC, to,pes, Tmrc,pes and the PESP in Ca2+ for
the Matsuoka etal 2003 model with physiological temperature (left panels) and with room
temperature (right panels). We observed that changing the rate constants back to room
temperature values did not change any of the four contraction characteristic curves or the
Ca2+. This shows that combining room temperature NL96 contraction to body tempera-
ture EP models should not affect the results obtained in this study. However it is important
to notice that most cell models do not produce large changes when temperatures are modi-






















The NL96 has limited cooperativity as the Hill coefficient used in simulations is 1.3 which
is lower than reported in experiments (between 2 and 6) [158, 159]. Negroni and Las-
cano published a newer version of their contraction model NL08 [160], with two major
changes. First they used a troponin system (TS), which consists of three adjacent troponin-
tropomyosin regulatory units as the basic unit; second, the cross-bridges have two possible
conformations: strong and weak, which results in six total states for the troponin system
instead of four. The newer model could reproduce better cooperative effect required for
force- relationships and force response to length steps. The Hill coefficient is calculated to
be from 4.15 to 4.00, corresponding to L=0.9 to 1.1m [160]. To investigate the influence
of the Hill coefficient, we implemented NL08 into Matsuoka etal 2003 and compared it
with the original Matsuoka model (with NL06). Results are shown in Fig. D.3. We found
no notable difference in the four contractile characteristic curves. The postextrasystolic
potentiation in Ca2+ is also retained except for the reduced maximum value of [Ca2+]i.
The Hill coefficient mainly determines the absolute value of force as a function of Calcium
concentration. Since the MRCpes and PESPC are normalized (to the prime beat) force






















Figure E.1: APD for different pacing cycle lengths.
213





Studies were performed using hearts obtained from adult mongrel dogs of either sex weigh-
ing 10 to 30 kg (n=7). The dogs were anesthetized with Fatal-Plus (390 mg/mL pentobar-
bital sodium; Vortex Pharmaceuticals; 86 mg/kg IV) and their hearts were excised rapidly.
Both coronary arteries were cannulated with polyethylene tubing, and the whole atrial my-
ocardium (both right and left) or the left ventricular myocardium (without the septum) were
excised and suspended in a heated (37◦C) bath where they were continuously both perfused
and superfused with normal Tyrodes solution. Oxygen level, action potential morphology
and speed were monitored throughout the experiments. No ischemia was found in the
tissue. After 15 to 30 minutes of equilibration, voltage-sensitive dye Di 4 ANEPPS (10
µM/L bolus) and Blebbistatin (10 µM/L) were then added to stain the preparation and pre-
vent motion artifact respectively. Arrhythmias in ventricles were induced by fast pacing.
The dominant period of VF was varied between 60ms and 150ms. Arrhythmias in atria
were induced by applying acetylcholine (ACh) (1-4 µM) before pacing. By adjusting the
concentration of Ach, the dominant period of arrhythmia was varied between 30 and 65ms,
which provided an opportunity to create arrhythmias that simulated atrial tachycardia, atrial
flutter, and AF in an intact heart. Both VF and AF are presented by multiple coupled spiral
waves. If shocks were not applied, fibrillation was persistent (maximum time tracked was
2 hours, minimum time 5 minutes). Figure F.1A shows the experimental setup, which con-
sists of a CCD camera, LED lights, bath with pumping system that can circulate perfusion
solution and control temperature. Figure F.1B zooms in to the bath where the tissue is place
in the center with four electrodes on the side. In experiments, only two electrodes at a time
215
will be connected to stimulus isolator. Figure F.1C shows the thin atria tissue.
F.2 Electrodes and pacing
Field stimulating electrodes consisted of 1 cm × 5 cm platinum plates embedded in epoxy
and were place on either side of the preparation, 10cm apart (Figure F.1B). The electrodes
were perpendicular to the surface of the ventricle (and atria). With the slab electrodes
thicker than the preparation, we expect activations at all parallel surfaces to be similar to the
top visualized one. Pacing and far-field stimuli consisted of rectangular pulses delivered,
respectively, with a bipolar electrode and stimulus isolator (World Precision Instruments)
and a function generator (Agilent 33220A) coupled to a power amplifier (Kepco BOB 100
to 4 mol/L) capable of delivering field strengths from 0.01 to 4.6 V/cm at cycle lengths as
short as 30 ms. The field strength between the electrodes was measured using two Teflon-
coated silver wires 5-7 cm apart and immersed in the bath. The electric field is calculated
by E=∆V/L with ∆V being the potential difference between the two sides of the electrode
and L being the distance in between.
F.3 Optical mapping
Excitation light was produced by 16 high-performance light-emitting diodes (Luxeon III
star, LXHL-FM3C, wavelength 530 ± 20 nm) driven by a low-noise constant-current
source. The illumination efficiency was significantly enhanced by collimator lenses (Lux-
eon, LXHL-NX05). The fluorescence emission light was collected by a Navitar lens (DO-
2595, focal length 25 mm, F/# 0.95), passed through a long-pass filter (<610 nm), and im-
aged by a 128×128 back-illuminated EMCCD array (electron-multiplied charge coupled
device, Photometrics Cascade 128+). The signal was digitized with a 16bit A/D converter
at a frame rate of 511 Hz. The PCI interface provided high-bandwidth uninterrupted data
transfer to the host computer. The instantaneous dominant frequency of an arrhythmia was
obtained in real time by calculating the fast Fourier transformation (FFT) of the signal
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Figure F.1: Ex vivo experiment setup. (A) Optical mapping setup. (B) Defibrillation setup
for either the 1 shock or LEAP. Picture shows tissue preparation (center) and four elec-
trodes on the side. Defibrillation was performed using only one of the two pair of parallel
electrodes. (C) Picture showing right canine atria with very thin regions of tissue. (D)
Extended time signal from one pixel during VF.
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recorded from 1 pixel in the center of the preparation in real time.
F.4 LEAP and one-shock defibrillation protocol
For the LEAP experiments, a sequence of either 5 or 10 pulses was applied after the induc-
tion of arrhythmia with a 5 ms pulse duration and a cycle length 5-10 ms below or above the
dominant cycle length of the arrhythmia. A series of recordings was made in each exper-
iment with each recording lasting up to 15 seconds in duration. Field strength was varied
and applied from the threshold level of activation (0.25 V/cm), as determined prior to ar-
rhythmia induction, until arrhythmia termination was achieved or the maximal deliverable
field strength was reached (∼ 4.6V/cm). After the arrhythmia termination was achieved,
the arrhythmia was re-induced and standard one shock defibrillation was performed on the
same hearts and the minimum energy required to terminate fibrillation was compared with
LEAP.
F.5 Data Analysis
After masking out the area that either no heart tissue is presented (bath etc.) or the tissue
that is not well perfused by the voltage-sensitive dye Di 4 ANEPPS, which leads to signal
too noisy to recognize, we smooth the data by averaging both spatially and temporally
with a Gaussian filter and the remove drift using piece-wise linear function based on action
potential period.
When calculating fraction of tissue excited (FTE), we first normalize the train of voltage
signal of every pixel from 0.0 to 1.0. We pick 0.4 as the threshold and consider the pixel
activated when the voltage is above that. We tested that changing the threshold from 30%
to 50% does not change much of the results.
In general, activation time in literature such as APD is defined by different authors
with different thresholds, typically 90%, 75% or 50% of the repolarization amplitude. In
this study, we consider the cell activated when the membrane potential is well above Na+
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activation threshold (normally, action potential is from -80mV to 20mV; the activation
threshold for Na+ is -60mV; 40% of a normal action potential amplitude is -40mV).
F.6 Statistics analysis
Data are expressed as mean±SD. Two-Sample t-test is performed on:
1. Peak dFTE/dt during (i) LEAP (sample size: 30) and (ii) standard one-shock defib-
rillation (sample size: 19) in experiments;
2. Percentage of trials that terminate arrhythmia within 5 shocks during (i) upslope
(sample size: 5) and (ii) downslope (sample size: 5) of FTE in LEAP simulations.
The first t-test is to determine whether LEAP and standard one-shock defibrillation
synchronize tissue at the same rate in experiments. We use dFTE/dt as an indicator for
how fast shocks synchronize tissue. The second t-test is to determine whether the LEAP
efficiency is the same when the first shock is applied at the upslope of FTE or downslope
of FTE in simulations. We use the percentage of trials successfully terminate arrhythmia
within five shocks as an indicator for the shock efficiency. MATLAB function ttest2 is used




Movie 1. Voltage and calcium in two consecutive beats for pacing cycle lengths from 350 to
140 ms when stimulation was applied at the base of the heart.
Link: https://youtu.be/PMdaUVDWXdo
Movie 2. Voltage and calcium in two consecutive beats for pacing cycle lengths from 350 to
140 ms when stimulation was applied at the apex of the heart.
Link: https://youtu.be/fHBApGL0G5k
Movie 3. Voltage and phase of LEAP terminating VF in Figure 6.1; E = 1.4V/cm.
Link: https://youtu.be/To-GMbOcyFk
Movie 4. Voltage of LEAP terminating AF in dog atria.
Link: https://youtu.be/XcNrPB2-UPo
Movie 5. Voltage and phase of LEAP failed to synchronize VF; E = 0.9V/cm.
Link: https://youtu.be/54TLDCfmSMo
Movie 6. Voltage and phase of LEAP terminating spiral waves in simulations in Figure 6.5; T
= 190ms.
Link: https://youtu.be/7zdnROzUDks
Movie 7. Voltage and phase of LEAP failed to terminate the spiral waves with 10 shocks (T =
164ms) in simulation.
Link: https://youtu.be/5ki uG7Jmrg
Movie 8. Voltage and FTE of LEAP terminating four spiral waves in simulation with pacing
period T=201ms and first shock at tm=590ms.
Link: https://youtu.be/oKUUGj8Gsec
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Movie 9. Voltage and FTE of LEAP terminating four spiral waves in simulation with T=181ms
and tm=590ms.
Link: https://youtu.be/NubdY0scgPg
Movie 10. Voltage and FTE of LEAP terminating four spiral waves in simulation with T=221ms
and tm=590ms.
Link: https://youtu.be/PRql5zkxbYU
Movie 11. Voltage and FTE of LEAP failed to terminate four spiral waves in simulation with
T=181ms and tm=670ms.
Link: https://youtu.be/FVgv0nE9-U8
Movie 12. LEAP showed similar results as anti-tachycardia pacing (ATP) when terminating a
single stable spiral and it has the advantage over ATP if the spiral is pinned to a
heterogeneity. When fast multiple spiral waves are presented, the more complex
the spirals are, the more energy will be required for LEAP. For example, in the 4-
sprial wave system in simulation, LEAP with E=1.05V/cm failed to terminate the
spirals with 10 shocks whereas in the 1-sprial wave system, the same electric field can
terminate the spiral in 4 shocks. In both situations, the first shocks were applied on
the downslope of FTE. Shock period is 221ms, 10% above the dominant period of the
arrhythmia. Link: https://youtu.be/7V7QC0v6A64 https://youtu.be/OZQXe0LpgN0
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